Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 171,118 Raw stories ingested 22,662 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 49s ago
  • FMP Forex News Fetch every 5 min 2m ago
  • CoinGecko News Fetch every 5 min 4m ago
  • FIO Stock News Fetch every 10 min 8m ago
  • Patria Stock News Fetch every 10 min 8m ago
  • Editorial rewrite Rewrite every minute 49s ago
  • Asset sync Assets every 1 hour 57m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-06-12 17:03 2mo ago
2026-05-20 05:02 3mo ago
CoStar Data Shows Glasgow City Centre Office Leasing Hits 230,000 Sq. Ft. in Q1 2026
CSGP CoStar Group
FMP Stock News
Original source text
LONDON--(BUSINESS WIRE)--Glasgow’s city centre recorded its highest quarterly office take-up since 2021, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets.

Take-up in the first three months of the year rose 85% quarter-on-quarter and 34% year-on-year. On a rolling four-quarter basis, occupier demand remained stable at around 600,000 sq. ft., up more than a third on the average between H2 2022 and H1 2024.

“Activity was driven by a return of larger deals, with three lettings above 20,000 sq. ft. signed in the city centre in Q1, more than in the whole of 2025,” said Grant Lonsdale, senior director of market analytics at CoStar Europe. “This pushed the average city centre deal size to around 6,000 sq. ft. in Q1 and 4,600 sq. ft. on a rolling annual basis, roughly 50% higher than two years earlier and the highest since Q3 2021.”

A total of 28 lettings below 5,000 sq. ft. were recorded in the City Core in Q1, taking the rolling four-quarter total to 133, nearing a record high.

Vacancy remains elevated at 12.4% across Glasgow and 15.8% in the city centre.

The full analysis can be found here.

For more information about the company and its products and services, please visit www.costargroup.com.

About CoStar Group

CoStar Group (NASDAQ: CSGP) is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted over 131 million average monthly unique visitors in the first quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.
2026-06-12 17:03 2mo ago
2026-05-20 18:08 3mo ago
Homes.com Shares Most Expensive Home Sales Across Major U.S. Markets in April
CSGP CoStar Group
FMP Stock News
Original source text
-

$47 million estate in Miami marks the highest publicly marketed home sale of the month, with multiple markets exceeding transactions above $20 million

ARLINGTON, Va.--(BUSINESS WIRE)--Homes.com, a CoStar Group (NASDAQ: CSGP) leading online residential marketplace, published the most expensive publicly marketed home sales across major U.S. metropolitan areas for the month of April. The full analysis is available here.

The list highlights the top closed sales in leading markets nationwide based on publicly marketed transactions recorded in multiple listing service (MLS) data. April’s most expensive sale occurred in Miami, where a waterfront estate in Coral Gables sold for $47 million. Los Angeles and Phoenix followed with $41 million and $32 million transactions respectively, while San Francisco recorded the fourth-highest publicly marketed sale at $27.5 million.

The full roundup of the most expensive publicly marketed home sales includes:

Miami: $47 million Los Angeles: $41.3 million Phoenix: $32.5 million San Francisco: $27.5 million New York City: $22 million Tampa: $19.1 million Seattle: $14 million Las Vegas: $10.5 million Boston: $9.5 million Atlanta: $7. 8 million San Diego: $7.4 million Washington, D.C.: $7 million Minneapolis: $6.7 million Chicago: $6.3 million Philadelphia: $5.8 million Denver: $5.6 million Charlotte: $5.2 million Nashville: $5.1 million Cleveland: $3.2 million A $21.5 million mansion in Houston’s River Oaks neighborhood was also included in the April roundup of top sales but is not reflected in the chart, as Texas is a nondisclosure state where home sale prices are not required to be publicly reported.

The distribution of these top-tier transactions highlights the continued concentration of ultra-luxury sales at the very top end of the market, led by water-view properties across several major metros. Miami, Los Angeles, Phoenix, San Francisco and New York City all recorded publicly marketed sales above $20 million, underscoring the continued demand for luxury homes with premium views and high-end amenities.

Based on MLS data found on Homes.com, the analysis captures publicly marketed transactions and does not include private or off-market deals, which are common in the highest tier of the housing market.

For more information and insights on the latest homebuying and selling market trends, visit Homes.com.

About Homes.com

The Homes.com Network is the fastest-growing residential real estate marketplace and the second largest in the United States. Homes.com is a brand of CoStar Group (NASDAQ: CSGP), a global leader in commercial real estate information, analytics, and online marketplaces, which acquired the platform in 2021.

Homes.com is the first major U.S. real estate portal to focus first on helping homeowners and their agents leverage the marketing power of the internet to bring more potential buyers to their listings. Homes.com’s unparalleled content and search capabilities bring millions of buyers and sellers to the site where they can seamlessly connect with agents. On average, Homes.com’s Members gain $36,400 in commission in their first year* because they offer the home sellers a real estate portal that works for them not against them.

The Homes.com Network reached an audience of 108 million average monthly unique visitors in 2025** and organic traffic to Homes.com was up more than 100% year-over-year every month of the first quarter of 2026. For more information, visit Homes.com.

*Based on an internal analysis of approximately 11,000 Member agents, which showed an average annual commission increase of $36,400. This figure represents an average and is not a guarantee of future performance. Individual results may vary based on market conditions, agent activity, and other factors.

** The Homes.com Network (which includes Homes.com, the Apartments Network, and the Land Network) average monthly unique visitors (108 million) for the year ended December 31, 2025, according to Google Analytics.

About CoStar Group

CoStar Group (NASDAQ: CSGP), an S&P 500 company, is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted 131 million average monthly unique visitors in the first quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.

More News From CoStar Group

Back to Newsroom
2026-06-12 17:03 2mo ago
2026-05-22 03:00 3mo ago
CoStar Data Shows Office Yield Gap Narrowing Between London and the Big Six
CSGP CoStar Group
FMP Stock News
Original source text
LONDON--(BUSINESS WIRE)--Improving investor sentiment narrows the office yield gap between London and major regional markets, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets.

Based on a three-quarter trailing average, London’s transaction-based office yield rose 50 basis points to 6.5% in Q1 2026, up from 6% in Q4 2025 and a recent low of 5.8% in Q3 2025.

“Average office yields outside London fell slightly after reaching a 12-year high at the end of 2025, with regional yields declining by 30 basis points in Q1 2026, though remaining elevated at 10.3%,” said Mark Stansfield, senior director of market analytics at CoStar Europe. “The yield spread between London and the regions narrowed to 370 basis points, from 480 basis points two quarters ago, but remains historically wide.”

Average central London office yields rose by 30 basis points to 5.7%, while Big Six office yields compressed by 30 basis points to 8.8%.

“The yield spread between central London and the Big Six narrowed to 310 basis points,” said Stansfield. “This is down from 430 basis points two quarters ago, when the gap reached its widest this century.”

Retail yields held at 7.1%, while industrial yields compressed by 20 basis points to 6.9%, halting the increases seen throughout 2025.

The full analysis can be found here.

For more information about the company and its products and services, please visit www.costargroup.com.

About CoStar Group

CoStar Group (NASDAQ: CSGP) is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted over 131 million average monthly unique visitors in the first quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.
2026-06-12 17:03 2mo ago
2026-05-22 10:46 3mo ago
Why CoStar Group (CSGP) is a Top Growth Stock for the Long-Term
CSGP CoStar Group
FMP Stock News
Original source text
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: CoStar Group (CSGP - Free Report) CoStar Group is a prominent provider of online real estate marketplaces, data, and analytics in the United States. The company has been expanding its international footprint with operations in the United Kingdom, Spain, France, and Germany. CoStar Group's services cover various property types, including office, retail, industrial, multifamily, commercial land, mixed-use, and hospitality. Through the acquired businesses of Homesnap and Homes.com, it offers an online platform for residential real estate agents and brokers. Homebuyers can view residential property listings through the portal.

CSGP is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.

Additionally, the company could be a top pick for growth investors. CSGP has a Growth Style Score of B, forecasting year-over-year earnings growth of 54% for the current fiscal year.

Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.02 to $1.34 per share. CSGP boasts an average earnings surprise of +23%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, CSGP should be on investors' short list.
2026-06-12 17:03 2mo ago
2026-05-26 20:28 3mo ago
CoStar Group Inc (CSGP) Shares Fall 4.2% -- What GF Score of 74 Tells Investors
CSGP CoStar Group
FMP Stock News
Original source text
On May 26, 2026, CoStar Group Inc (CSGP) shares fell 4.2% to a current price of $32.52, continuing a downward trend that has seen the stock decline by 51.6% yea
2026-06-12 17:03 2mo ago
2026-05-28 09:00 3mo ago
Apartments.com Releases Multifamily Rent Growth Report for May 2026
CSGP CoStar Group
FMP Stock News
Original source text
-

National rent growth remains positive in May as spring leasing season momentum continues to lag

ARLINGTON, Va.--(BUSINESS WIRE)--Today Apartments.com, an industry-leading online marketplace of CoStar Group, Inc. (NASDAQ: CSGP), published its latest report on multifamily rent trends for May 2026.

U.S. apartment rents increased modestly in May, with the national average rising to $1,737, a +0.2% increase from April’s upwardly revised level of $1,733. This marks the sixth consecutive month of positive rent growth following a period of flat to declining monthly performance in the second half of 2025. On an annual basis, rent growth was flat at +0.7% in May 2026, in line with April’s reading and down from +1.3% one year earlier.

Both March and April were initially reported as +0.2% month over month and have been revised upward to +0.3%.

While apartment rent growth typically peaks at this stage of the spring leasing season, gains in May were modest, suggesting that spring leasing season momentum is more restrained than in a typical year. While monthly rent growth has stabilized since late 2025, supply conditions and more measured demand growth continue to restrain pricing momentum nationally.

Rent growth was broad-based across regions in May, with all five regions posting month-over-month increases. The Northeast and Pacific regions led on a monthly basis, both rising +0.3%, followed by the Midwest region at +0.2% and the South and Mountain regions, both at +0.1%. On an annual basis, regional performance was more uneven. The Midwest recorded the strongest year-over-year rent growth at +2.0%, followed by the Northeast at +1.3% and the Pacific at +1.2%. In contrast, rents declined year over year in the South, down -0.8%, and in the Mountain region, down -1.7%. Performance across Western markets continues to diverge, with supply-heavy Mountain metros facing greater pressure than more supply-constrained Pacific markets.

At the metro level, rent growth remained widespread in May, with 43 of the top 50 markets posting month-over-month increases, down slightly from 45 markets in April. San Jose led monthly rent growth with a +1.2% increase, followed by Tucson at +0.9% and San Francisco at +0.8%. Only seven major markets recorded monthly rent declines, with Las Vegas down -0.3%, Richmond down -0.2%, Fort Lauderdale, Phoenix, Los Angeles and Louisville each down -0.1%, and San Antonio also posting a slight decline.

On an annual basis, San Francisco continued to outperform, posting rent growth of +8.4%, followed by San Jose at +4.9%, Norfolk at +4.4% and Chicago at +2.9%. Meanwhile, markets experiencing the largest supply additions remained under pressure, led by Austin and San Antonio, both with -3.3% annual declines, followed by Denver at -3.1% and Las Vegas at -2.5%, reflecting new supply continuing to outpace demand.

Regionally, modest monthly rent gains are now widespread across the country, though year-over-year performance remains uneven and closely tied to local supply conditions. While many markets have moved past peak construction activity, a substantial—though gradually easing—inventory overhang continues to weigh on rent growth nationally as the 2026 spring leasing season progresses.

About CoStar Group

CoStar Group (NASDAQ: CSGP) is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted 131 million average monthly unique visitors in the first quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.

More News From CoStar Group

Back to Newsroom
2026-06-12 17:03 2mo ago
2026-05-28 10:00 3mo ago
Apartments.com Releases Multifamily Rent Growth Report for May 2026
CSGP CoStar Group
FMP Stock News
Original source text
Today [url="]Apartments.com[/url], an industry-leading online marketplace of CoStar Group, Inc. (NASDAQ: CSGP), published its latest report on multifamily rent
2026-06-12 17:03 2mo ago
2026-05-28 12:31 3mo ago
Why Is CoStar (CSGP) Down 5.3% Since Last Earnings Report?
CSGP CoStar Group
FMP Stock News
Original source text
It has been about a month since the last earnings report for CoStar Group (CSGP - Free Report) . Shares have lost about 5.3% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is CoStar due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.

CoStar Group Q1 Earnings Beat Estimates, Revenues Up Y/YCoStar Group reported non-GAAP earnings of 23 cents per share in the first quarter of 2026, which surpassed the Zacks Consensus Estimate by 30.16%. The company reported earnings of 15 cents per share in the year-ago quarter, up 64.3% year over year.

Revenues of $897 million rose 22.5% year over year, missing the Zacks Consensus Estimate by 0.06%.

The quarter featured sharp profitability improvement, supported by cost efficiencies and strong performance across its real estate marketplaces. Annualized net new bookings were $67 million, up 20% from the year-ago period.

CoStar Sees Residential Growth Outpacing CRECoStar Group reported balanced growth across its two operating segments, with Residential Real Estate continuing to expand faster than the Commercial Real Estate portfolio. Commercial Real Estate revenue (52.6% of revenues) was $472 million, up 15.4% year over year, while Residential Real Estate revenue (47.4% of revenues) was $425 million, up 31.6% year over year.

Within Commercial Real Estate, CoStar Group’s revenues (36.9% of revenues) were $331, which increased 8.5% year over year.  LoopNet’s revenues (9.5% of revenues) were $85 million, which increased 16.4% year over year.  Other Commercial Real Estate revenues (6.2% of revenues) were $56 million, which increased 80.6% year over year, aided by contributions from acquired operations.

CSGP Leans on AI and Marketplaces to Drive EngagementIn the first quarter of 2026, the company highlighted the launch of the Homes.com AI application and pointed to stronger consumer interaction metrics tied to AI-driven search experiences, alongside ongoing progress in member growth for Homes.com.

In the reported quarter, CSGP continued product enhancements at Apartments.com, including expanded natural-language and voice-search capabilities, and highlighted pricing and inventory initiatives at LoopNet designed to broaden advertiser participation. These initiatives collectively reinforce CoStar Group’s strategy of pairing marketplace scale with technology-led differentiation to support sustained growth and expanding profitability.

CSGP Delivers Operating Leverage as EBITDA DoublesIn the reported quarter, selling and marketing expenses increased 14.1% year over year to $421 million. As a percentage of revenues, selling and marketing expenses were 46.9% compared with 50.4% in the year-ago quarter. General and administrative expenses, as a percentage of revenues, contracted 520 basis points (bps) on a year-over-year basis to 14%.

Software development expenses, as a percentage of revenues, expanded 30 bps, while Customer base amortization expenses rose 180 bps year over year.
Operating expenses increased 12.2% year over year to $698 million. As a percentage of revenues, operating expenses decreased 720 bps year over year to 77.8%.

Adjusted EBITDA was $132 million compared with the year-ago quarter’s $66 million. The adjusted EBITDA margin expanded 570 bps to 14.7%.

CSGP’s Balance Sheet & Cash Flow StatementCoStar Group reported cash and cash equivalents of $1.21 billion as of March 31, 2026, compared with $1.63 billion as of Dec. 31, 2025.

The company had a long-term debt of $994 million as of March. 31, 2026, compared with $993 million as of Dec. 31, 2025.

Cash generated by operating activities was $152 million in the reported quarter compared with $430 million in the previous quarter.

In the first quarter of 2026, CoStar Group repurchased 11.4 million shares for $505 million, with most of this executed through an accelerated share repurchase plan.

CoStar Group’s OutlookManagement reaffirmed 2026 revenue guidance of $3.78-$3.82 billion, implying continued double-digit growth at the midpoint. Adjusted EBITDA guidance for 2026 increased to $780-$820 million, representing a higher margin profile than previously expected.

For the second quarter of 2026, the company expects revenues between $922 million and $932 million. Adjusted EBITDA is expected to be in the range of $160-$180 million, with adjusted earnings per share anticipated to be in the range of 27 cents to 30 cents per share, signaling further sequential improvement in profitability.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.

The consensus estimate has shifted 14.55% due to these changes.

VGM ScoresCurrently, CoStar has a nice Growth Score of B, however its Momentum Score is doing a bit better with an A. However, the stock has a grade of C on the value side, putting it in the middle 20% for this investment strategy.

Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, CoStar has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerCoStar belongs to the Zacks Computers - IT Services industry. Another stock from the same industry, ServiceNow (NOW - Free Report) , has gained 14.9% over the past month. More than a month has passed since the company reported results for the quarter ended March 2026.

ServiceNow reported revenues of $3.77 billion in the last reported quarter, representing a year-over-year change of +22.1%. EPS of $0.97 for the same period compares with $0.81 a year ago.

For the current quarter, ServiceNow is expected to post earnings of $0.86 per share, indicating a change of +4.9% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

ServiceNow has a Zacks Rank #4 (Sell) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.
2026-06-12 17:03 2mo ago
2026-05-29 08:00 3mo ago
CoStar Group to Acquire Zonda, the Leader in New Home Data, Analytics, and Online Marketplaces
CSGP CoStar Group
FMP Stock News
Original source text
Acquisition adds the homebuilding industry's leading B2B information platform - used by builders, developers, and lenders - and brings NewHomeSource.com, the category-defining new home marketplace, into CoStar Group's family of marketplaces.

ARLINGTON, Va.--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, and analytics across the property markets, today announced that it has entered into a definitive agreement to acquire Zonda, a leading provider of new home construction data, homebuilder software, and residential real estate marketplaces, for $800 million in cash.

Zonda serves more than 3,000 customers across the homebuilding ecosystem, including many of the largest residential builders, developers, suppliers, and lenders in North America. Its platform delivers end-to-end solutions spanning land acquisition, development planning, homebuilding analytics, construction forecasting, community marketing, operational workflow management, and online new home marketplaces. Zonda is an attractive B2B business with strong profit margins. The majority of its revenue is subscription-based, with an impressive 104% net customer retention.

At the core of Zonda is a proprietary, lot-level database covering new home communities, land development activity, construction status, home sales, and builder operations. This data and the software built around it are deeply embedded in builder workflows and are widely used to support underwriting, land strategy, capital allocation, development planning, forecasting, and sales operations across the industry.

Zonda also operates NewHomeSource and Livabl, two leading online new home marketplaces in the United States and Canada. Top homebuilders contribute listings directly to these marketplaces, giving buyers broad visibility into new home inventory across the development ecosystem. Zonda’s platforms offer comprehensive listing experiences — including floor plans, virtual tours, pricing, incentives, and community details — designed to guide buyers from early research through purchase. Because these marketplaces feature new construction exclusively, they give builders highly targeted consumer marketing, lead generation, and merchandising — uncluttered by resale inventory.

According to the Census, the annual value of new residential construction in the U.S. approaches $1 trillion - a market materially larger than the annual rent rolls of the institutional apartment and office sectors that CoStar Group has so successfully monetized.

CoStar Group believes Zonda's builder relationships, workflow integrations, marketplace platforms, and market intelligence will create meaningful cross-sell opportunities across the company's commercial, residential, multifamily, lending, and analytics businesses.

The acquisition will also pair Zonda's Envision visualization and digital merchandising capabilities with Matterport's industry-leading spatial technology. Together, they will create richer digital experiences for builders and consumers and improve how new construction homes are marketed, visualized, and discovered online.

"Zonda has built an extraordinary business with deep relationships across the homebuilding industry and one of the most valuable proprietary datasets in new home real estate," said Andy Florance, Founder and Chief Executive Officer of CoStar Group. "This acquisition extends CoStar Group's leadership into a major new segment of the real estate industry and strengthens our ability to provide clients with comprehensive information solutions across every major real estate segment. We believe the combination will deliver deeper insights, workflow efficiencies, and analytics to the homebuilding industry, while strengthening our core information offerings and significantly expanding our new home marketplace capabilities."

The acquisition is expected to be accretive to adjusted EPS in the first full year of ownership and to close in the second half of 2026, subject to customary closing conditions and required regulatory approvals.

BofA Securities is serving as financial advisor and Latham & Watkins LLP is serving as legal advisor to CoStar Group.

About CoStar Group

CoStar Group (NASDAQ: CSGP), an S&P 500 company, is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted 131 million average monthly unique visitors in the first quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.

Forward-Looking Statements

This news release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act including, without limitation, statements regarding CoStar's expectations or beliefs regarding the future and the pending acquisition of Zonda, the expected timetable for completing the transaction, benefits of the transaction and future opportunities for the combined businesses. These statements are based upon current beliefs and are subject to many risks and uncertainties that could cause actual results to differ materially from these statements. The following factors, among others, could cause or contribute to such differences: risks associated with the ability to consummate the pending transaction and the timing of the closing of the pending transaction; the ability to successfully integrate operations and employees; the ability to realize anticipated benefits from the transaction as rapidly or to the extent anticipated; the potential impact of announcement of the transaction or consummation of the transaction on business relationships, including with employees, customers, suppliers and competitors; and costs, fees, expenses and charges related to the transaction. More information about potential factors that could cause results to differ materially from those anticipated in the forward-looking statements include, but are not limited to, those stated in CoStar’s filings from time to time with the Securities and Exchange Commission, including in CoStar’s Annual Report on Form 10-K for the year ended December 31, 2025 and Form 10-Q for the quarterly period ended March 31, 2026, each of which is filed with the SEC, including in the “Risk Factors” section of those filings, as well as CoStar’s other filings with the SEC available at the SEC’s website (www.sec.gov). All forward-looking statements are based on information available to CoStar on the date hereof, and CoStar assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
2026-06-12 17:03 2mo ago
2026-05-29 08:15 3mo ago
MidOcean Partners Signs Definitive Agreement to Sell Zonda to CoStar Group
CSGP CoStar Group
FMP Stock News
Original source text
-

Marks the Firm’s Third Liquidity Event This Month and Another Successful Exit for MidOcean’s Business Services Vertical

NEW YORK--(BUSINESS WIRE)--MidOcean Partners (“MidOcean” or the “Firm”), a premier New York-based alternative asset manager specializing in middle market private equity, alternative credit, and structured equity, announced today the signing of the sale of Bora, Inc. and its subsidiaries (collectively, “Zonda” or the “Company”) to CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group”).

Zonda is the #1 data, marketplace, and software platform for the new home ecosystem. Zonda’s end-to-end platform spans land discovery, homebuilding, home discovery, and homebuying, and is delivered through three integrated offerings: subscription-based data and intelligence covering more than 500 housing metrics across North America; the leading new-home marketplace in the U.S. and Canada; and a full suite of software solutions for the virtual home evaluation experience, including visualization, customization, and tours. Customers rely on Zonda’s proprietary, AI-driven platform for mission-critical, daily decision making across the new home value chain.

MidOcean executed a focused value creation strategy that unified disparate industry assets into a comprehensive purpose-built platform for the new home market and significantly expanded the Company’s offerings across data, marketplaces, and software. During MidOcean’s ownership, Zonda completed nine strategic add-on acquisitions, broadened geographic coverage, invested heavily in proprietary and patented AI-driven data collection and workflow tools, and launched new products targeted to this $27 billion+ total addressable market. The Company more than doubled in scale, materially expanded margins, and achieved more than 50 consecutive quarters of year-over-year ARR growth – demonstrating a successful track record across all housing market conditions.

Sara Badham, Managing Director at MidOcean, commented, “With Zonda’s visionary management team, we set out to create the preeminent platform for data, insights and technology across the residential housing ecosystem. We continually invested behind that vision, in strategic acquisitions, technology, product and talent. Zonda is a trusted partner to its customers and a trusted source of intelligence across the market. We are incredibly proud of what we have built together with the Zonda team and we look forward to watching the Company’s continued success as part of CoStar Group.”

“MidOcean’s strategic insight, operational support, and capital partnership were instrumental in transforming Zonda into the platform it is today. We are excited to combine with the CoStar Group – a global leader in real estate information, analytics, and marketplaces – and look forward to continuing to deliver exceptional value to our customers as part of a larger platform with shared ambitions,” added Jeff Meyers, Founder and Chief Executive Officer of Zonda.

Houlihan Lokey Capital, Inc. served as lead financial advisor to MidOcean. Solomon Partners Securities, LLC. also served as a financial advisor to the Company. Gibson, Dunn & Crutcher LLP served as legal advisor to MidOcean.

About MidOcean Partners
MidOcean Partners is a premier New York-based alternative asset manager specializing in middle-market private equity, alternative credit, and structured equity. Since its inception in 2003, MidOcean Private Equity has targeted investments in high-quality middle-market companies in the consumer and business services sectors. MidOcean Credit Partners was launched in 2009 and currently manages a series of alternative credit strategies, collateralized loan obligations (CLOs), and customized separately managed accounts. In 2024, MidOcean expanded its platform to include structured equity, positioning the firm as a leading provider of capital solutions to the middle market. For more information, please visit https://www.midoceanpartners.com/.

About Zonda
Zonda is the #1 data, marketplace, and software platform purpose-built for the new home ecosystem. Leveraging more than 40 years of category leadership, Zonda serves more than 3,000 customers across the homebuilding lifecycle through proprietary data and intelligence, the leading new-home marketplaces in North America — NewHomeSource and Livabl — and integrated software solutions that power critical builder and industry workflows. Learn more at zondahome.com.

More News From MidOcean Partners

Back to Newsroom
2026-06-12 17:02 2mo ago
2026-06-01 19:54 3mo ago
CoStar Group Inc (CSGP) Shares Surge 5.2% -- What GF Score of 74 Tells Investors
CSGP CoStar Group
FMP Stock News
Original source text
On June 01, 2026, CoStar Group Inc (CSGP) shares rose 5.2% today, closing at $33.86. This price is significantly lower than its 52-week high of $97.43 and close
2026-06-12 17:02 2mo ago
2026-06-03 07:19 3mo ago
CoStar Data Shows Birmingham Posted Highest Retail Investment Volumes Since 2016
CSGP CoStar Group
FMP Stock News
Original source text
LONDON--(BUSINESS WIRE)--Shopping centre sales pushed Birmingham retail investments to a 10-year high, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets.

The rolling 12-month average quarterly volume reached £202 million to the end of Q1, double the five-year annual average.

“The pricing and scale of acquisitions reflect confidence in Birmingham’s position as a core retail destination, supported by strong footfall, a diverse occupier mix and continued inward investment into the city centre,” said Giles Tebbitts, director of market analytics at CoStar Europe. “For institutional capital, these assets offer secure income and long-term repositioning potential, particularly as consumer behaviour stabilises and experiential retail continues to anchor destination schemes.”

The 1.4 million sq ft Merry Hill shopping centre is now more than 96% let, with footfall rebounding to 15 million in 2025 and sales rising 4.3% year-on-year. A £125 million investment programme has reshaped the asset, delivering over 300,000 sq ft of new and upgraded space, including leisure operators and new retail concepts.

“Investor sentiment has softened following the escalation of the Iran conflict, increasing caution in capital markets, with some investors pausing deployment or repricing risk,” said Tebbitts. “Transactional activity has become more selective and pricing momentum has stabilised, contrasting with the stronger recovery seen in the months leading up to the conflict.”

The full analysis can be found here.

For more information about the company and its products and services, please visit www.costargroup.com.

About CoStar Group

CoStar Group (NASDAQ: CSGP) is a global leader in commercial real estate information, analytics, online marketplaces, and 3D digital twin technology. Founded in 1986, CoStar Group is dedicated to digitizing the world’s real estate, empowering all people to discover properties, insights, and connections that improve their businesses and lives.

CoStar Group’s major brands include CoStar, a leading global provider of commercial real estate data, analytics, and news; LoopNet, the most trafficked commercial real estate marketplace; Apartments.com, the leading platform for apartment rentals; Homes.com, the fastest-growing residential real estate marketplace; and Domain, one of Australia’s leading property marketplaces. CoStar Group’s industry-leading brands also include Matterport, a leading spatial data company whose platform turns buildings into data to make every space more valuable and accessible; STR, a global leader in hospitality data and benchmarking; Ten-X, an online platform for commercial real estate auctions and negotiated bids; and OnTheMarket, a leading residential property portal in the United Kingdom.

CoStar Group’s websites attracted over 131 million average monthly unique visitors in the first quarter of 2026, serving clients around the world. Headquartered in Arlington, Virginia, CoStar Group is committed to transforming the real estate industry through innovative technology and comprehensive market intelligence. From time to time, we plan to utilize our corporate website as a channel of distribution for material company information. For more information, visit CoStarGroup.com.
2026-06-12 17:02 2mo ago
2026-06-03 08:00 3mo ago
CoStar Data Shows Birmingham Posted Highest Retail Investment Volumes Since 2016
CSGP CoStar Group
FMP Stock News
Original source text
Shopping centre sales pushed Birmingham retail investments to a 10-year high, according to data from [url="]CoStar[/url], a global leading provider of online r
2026-06-12 17:02 2mo ago
2026-03-18 03:22 5mo ago
Lennox International, Inc. $LII Position Trimmed by Achmea Investment Management B.V.
LII Lennox International
FMP Stock News
Original source text
Achmea Investment Management B.V. cut its stake in shares of Lennox International, Inc. (NYSE: LII) by 3.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 91,071 shares of the construction company's stock after selling 2,822 shares during the period. Achmea Investment Management B.V. owned
2026-06-12 17:02 2mo ago
2026-03-20 10:19 5mo ago
Lennox Declares Quarterly Dividend
LII Lennox International
FMP Stock News
Original source text
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Lennox board of directors (NYSE: LII) approved a quarterly cash dividend of $1.30 per share of common stock, payable April15, 2026, to stockholders of record as of March 31, 2026.

About Lennox: Lennox (NYSE: LII ) is a leader in energy-efficient climate-control solutions. We are committed to sustainability and creating comfortable, healthier environments for residential and commercial customers. Our innovative portfolio includes cooling, heating, indoor air quality, and refrigeration systems, along with a comprehensive range of HVAC parts, supplies, and services that support the full lifecycle of customer needs. Additional information is available at www.lennox.com.

Media Contact
[email protected]

Investor Relations Contact
[email protected]

SOURCE Lennox International Inc.

Also from this source
2026-06-12 17:02 2mo ago
2026-03-23 19:00 5mo ago
Lennox International: A Solid Investment or Just Another HVAC Stock?
LII Lennox International
FMP Stock News
Original source text
Explore the exciting world of Lennox International (LII +1.94%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
2026-06-12 17:02 2mo ago
2026-04-08 08:00 5mo ago
Lennox Schedules First Quarter Results
LII Lennox International
FMP Stock News
Original source text
, /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, will report first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. An earnings conference call and webcast are scheduled for the same day at 8:30 a.m. Central Time. CEO Alok Maskara and CFO Michael Quenzer will provide a summary of the company's financial results and outlook, followed by a question-and-answer session.

To participate in the earnings conference call, please call 800-267-6316 (U.S.) or +1 203-518-9783 (international) at least 10 minutes prior to the scheduled start time and use conference ID LIIQ126. The conference call will also be webcast live at www.investor.lennox.com.

A replay of the conference call will be available until May 6, 2026, by calling toll-free 800-388-6197 (U.S.) or +1 402-220-1115 (international). The call also will be archived on the company's investor relations website.

About Lennox
Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information is available at www.lennox.com. 

Media Contact
[email protected]

Investor Relations Contact
[email protected]

SOURCE Lennox International Inc.
2026-06-12 17:02 2mo ago
2026-04-22 11:02 4mo ago
Lennox International (LII) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
LII Lennox International
FMP Stock News
Original source text
Lennox International (LII - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 29. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis manufacturer of furnaces, air conditioners and other products is expected to post quarterly earnings of $3.16 per share in its upcoming report, which represents a year-over-year change of -6.2%.

Revenues are expected to be $1.07 billion, down 0.6% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.79% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Lennox?For Lennox, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.03%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Lennox will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Lennox would post earnings of $4.76 per share when it actually produced earnings of $4.45, delivering a surprise of -6.51%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Lennox appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-06-12 17:02 2mo ago
2026-04-27 15:45 4mo ago
Expect Lennox International To Underperform The Market Moving Forward (Downgrade)
LII Lennox International
FMP Stock News
Original source text
Lennox International is downgraded to "Sell" due to weakening financials and an unattractive valuation. LII's Q4 2025 saw revenue decline 11.2% and net income fall to $142.5 million, with Home Comfort Solutions segment volumes down 17%. Despite management's optimistic 2026–2030 growth targets, even achieving them yields annualized returns below market averages.
2026-06-12 17:02 2mo ago
2026-04-29 06:45 4mo ago
Lennox Reports 2026 First Quarter Results
LII Lennox International
FMP Stock News
Original source text
Highlights
(All comparisons are year-over-year, unless otherwise noted)

Revenue $1.1 billion, up 6% GAAP Operating Income $164 million, down 3% GAAP diluted EPS $3.35, down 8% Maintaining full year EPS guidance range of $23.50 - $25.00 , /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, today reported first quarter financial results with $1.1 billion of revenue, $164 million of operating income, and $3.35 GAAP diluted earnings per share.

Revenue increased 6% to $1.1 billion. Total segment profit1 was $164 million, down 3%. Total segment margin1 was down 130 basis points to 14.4%. Adjusted diluted earnings per share decreased 8% to $3.35.

"Our results this quarter were supported by stabilizing end-markets and encouraging momentum across our strategic initiatives, including the integration of Duro Dyne and Supco. We remain confident in our strategy to deliver long-term shareholder value through differentiated growth and bolt-on M&A opportunities," said CEO, Alok Maskara. "While macro uncertainties persist, we are focused on productivity measures, supply chain optimization, and thoughtful pricing actions to offset inflationary pressures."

In Home Comfort Solutions, industry conditions started stabilizing during the first quarter, as expected. Revenue declined by 10%. While the segment experienced continued softness across both the one step and two step channels, this is a sequential improvement from the 21% decline in the fourth quarter. One-step results continued to be impacted by weak new home construction, while sentiment in the two-step channel improved as distributors began to restock ahead of the summer season. Segment margins declined 390 bps primarily driven by inflation and unfavorable absorption, partially offset by positive mix and price, acquisition contributions, and disciplined cost actions.

The Building Climate Solutions segment delivered another strong quarter, with organic sales increasing 26% and acquisitions contributing an additional 12% of growth. Segment margins improved by approximately 300 basis points, largely driven by volume improvement, including contributions from national account activity. Emergency replacement activity remained strong, and there were new national account wins across both equipment and service. As inventory levels normalize, the resulting absorption impact was partially offset by productivity and manufacturing efficiency improvements.

1 Includes unallocated corporate expenses

FIRST QUARTER 2026 FINANCIAL HIGHLIGHTS
(All comparisons are year-over-year, unless otherwise noted)

Revenue: $1.1 billion was up 6%, driven by revenue from completed acquisitions.

Operating Income: $164 million, down 3%, with operating profit margin of 14.4%, down 130 bps.

Total Segment Profit1: $164 million, down 3%, and total segment profit margin of 14.4%, down 130 basis points primarily driven by $32 million decrease from lower sales volumes; $31 million product cost primarily related to recent inflationary impacts and factory under absorption; and, $14 million of SG&A and distribution inflation and investments. This was partially offset by $63 million of mix/price benefits and $9 million from completed acquisitions.

Net Income: $117 million, or $3.35 per share, compared to $130 million, or $3.63 per share, in the prior-year quarter.

Adjusted Net Income: $117 million, or $3.35 per share, compared to $130 million, or $3.63 per share, in the prior-year quarter.

Cash Flow: Operating cash flow was $16 million compared to $36 million cash used in the prior-year quarter driven by less inventory growth. Net capital expenditures were $55 million compared to $25 million in the prior-year quarter. Share repurchases totaled $20 million.

Home Comfort Solutions: Business segment revenue was $650 million, down 10%. Segment profit was $87 million, down 30%, and segment margin was 13.3%, down 390 basis points. Segment profit declined $37 million compared to the prior-year quarter. The decrease was driven by lower sales volumes, resulting in a $56 million profit headwind, along with $23 million of product cost inflation and lower factory absorption and $1 million in other costs. This was partially offset by $41 million in mix/price benefits and $2 million from completed acquisitions.

Building Climate Solutions: Business segment revenue was $485 million, up 38%. Segment profit was $96 million, up $37 million or 63%, and segment margin improved 300 basis points to 19.7%. This increase reflects a $24 million profit benefit from higher sales volumes, $22 million in mix/price benefits, and $7 million from completed acquisitions. This was partially offset by $8 million in product cost inflation and lower factory absorption; and $8 million from other costs, including SG&A and distribution inflation and investments.

Corporate and Other: Corporate expenses were $19 million, up $4 million from the prior-year quarter.

1 Includes unallocated corporate expenses

FULL YEAR 2026 GUIDANCE
For full year 2026, we are updating revenue growth guidance to approximately 8%, including 4% benefit from completed acquisitions.

Earnings per share is still expected to be within the range of $23.50 to $25.00.

Free Cash Flow is still estimated to be within the range of $750 million to $850 million.

CONFERENCE CALL INFORMATION
A conference call to discuss the company's first quarter results will be held this morning at 8:30 a.m. Central Time. To participate in the earnings conference, please call 800-267-6316 (U.S.) or +1 203-518-9783 (international) at least 10 minutes prior to the scheduled start time and use conference ID LIIQ126. The conference call also will be webcast live on the company's investor relations web site at investor.lennox.com. A replay of the conference call will be available until May 6, 2026, by calling toll-free 800-388-6197 (U.S.) or +1 402-220-1115 (international). The call will also be archived on the company's investor relations website at investor.lennox.com.

ABOUT LENNOX
Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information on Lennox is available at Lennox.com or by contacting [email protected].

FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES
The statements in this document that are not historical statements, including statements regarding the 2026 full-year outlook and expected consolidated and segment financial results, as well as financial targets for future years, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on information currently available as well as management's assumptions and beliefs today. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from the results expressed or implied by the statements, and investors should not place undue reliance on them. Risks and uncertainties that could cause actual results to differ materially from such statements include risks that the North American HVAC and refrigeration markets perform worse than current assumptions. Additional risks include but are not limited to competition in the HVACR business; our ability to successfully develop and market new products or execute our business strategy; our ability to meet and anticipate customer demands; our ability to continue to license or enforce our intellectual property rights; our ability to attract, motivate, develop, and retain our employees, as well as labor relations problems; artificial intelligence technologies; a decline in new construction activity and related demand for our products and services; the impact of weather on our business; the impact of higher raw material prices and significant supply interruptions; product liability, warranty claims, or recalls; changes in environmental and climate-related legislation or government regulations or policies; changes in tax legislation; the impact of new or increased trade tariffs; improper conduct by any of our employees, agents, or business partners; litigation risks; general economic conditions in the United States and abroad; extraordinary events beyond our control; risks associated with our international operations; cyber-attacks and other disruptions or misuse of information systems; and our ability to successfully realize, complete and integrate acquisitions.

For information concerning these and other risks and uncertainties, see LII's publicly available filings with the Securities and Exchange Commission. LII disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

A reconciliation of non-GAAP financial measures appearing in this document to financial measures prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) are included in the Annex to this document.

This document includes forward-looking statements regarding segment profit, adjusted net income, adjusted diluted earnings per share, and free cash flow, which are non-GAAP financial measures. These non-GAAP financial measures are derived by excluding certain amounts from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts excluded is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period and the high variability of certain amounts, such as unusual gains and losses, the ultimate outcome of pending litigation, fluctuations in foreign currency exchange rates, changes in environmental liabilities, the impact and timing of potential acquisitions and divestitures, future restructuring costs, and other structural changes or their probable significance. We are unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures because such information is not available, and management cannot reliably predict the necessary components of such GAAP measures without unreasonable effort or expense. The unavailable information could have a significant impact on LII's full year GAAP financial results.

LENNOX INTERNATIONAL INC. AND SUBSIDIARIES

Consolidated Statements of Operations 

(Unaudited)

(Amounts in millions, except per share data)

For the Three Months
Ended March 31,

2026

2025

Net sales

$     1,135.1

$    1,072.6

Cost of goods sold

783.8

731.7

Gross profit

351.3

340.9

Operating Expenses:

Selling, general and administrative expenses

185.2

171.3

Losses and other expenses, net

2.2

2.8

Loss (income) from equity method investments

0.4

(1.2)

Operating income

163.5

168.0

Pension settlements

0.5

0.1

Interest expense, net

15.2

6.2

Other expense, net

0.9

0.9

Net income before income taxes

146.9

160.8

Provision for income taxes

29.7

31.2

Net income

$       117.2

$      129.6

Earnings per share – Basic(1):

$        3.37

$        3.65

Earnings per share – Diluted(1):

$        3.35

$        3.63

Weighted Average Number of Shares Outstanding - Basic

34.8

35.5

Weighted Average Number of Shares Outstanding - Diluted

35.0

35.7

(1) Amounts may not recalculate due to rounding.

Note: The 2025 amounts are adjusted to reflect the accounting method change from LIFO to FIFO that occurred in the fourth quarter of 2025.

LENNOX INTERNATIONAL INC. AND SUBSIDIARIES

Segment Net Sales and Profit

(Unaudited)

(Amounts in millions)

For the Three Months
Ended March 31,

2026

2025

Net Sales

Home Comfort Solutions

$        650.0

$      721.4

Building Climate Solutions

485.1

351.2

Total net sales

$      1,135.1

$    1,072.6

Segment Profit(1)

Home Comfort Solutions

$         86.5

$      123.9

Building Climate Solutions

95.6

58.8

Total segment profit

182.1

182.7

Corporate and other expenses(2)

(18.6)

(14.7)

Total segment profit, including unallocated Corporate and other expenses

163.5

168.0

Reconciliation to Operating income:

Restructuring charges





(Gain) loss on sale from previous dispositions





Acquisition costs





Operating income

$        163.5

$      168.0

 (1)

We define segment profit as a segment's operating income (loss) included in the accompanying Consolidated Statements of Operations, excluding:

Restructuring charges, Gain (loss) on sale of previous dispositions, and; Acquisition costs (2)

Corporate and other expenses include unallocated corporate costs related to corporate administrative functions such as tax, treasury, accounting, internal audit, legal and human resources.

Note: The 2025 amounts are adjusted to reflect the accounting method change from LIFO to FIFO that occurred in the fourth quarter of 2025.

LENNOX INTERNATIONAL INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(Amounts in millions, except shares and par values)

As of March 31, 2026

As of December 31, 2025

(Unaudited)

ASSETS

Current Assets:

Cash and cash equivalents

$                48.2

$                  34.2

Short-term investments

2.0

0.5

Accounts and notes receivable, net of allowances of $9.1 and $8.5 in 2026 and
     2025, respectively

647.9

578.8

Inventories, net

1,209.7

1,152.6

Other current assets

124.3

137.7

Total current assets

2,032.1

1,903.8

Restricted cash equivalents

19.0

18.5

Property, plant and equipment, net of accumulated depreciation of $1,064.3 and
     $1,043.9 in 2026 and 2025, respectively

917.6

887.2

Right-of-use assets from operating leases

404.4

356.3

Goodwill

503.7

497.2

Intangible assets, net of accumulated amortization of $42.4 and $38.3 in 2026
     and 2025, respectively

269.7

273.0

Deferred income taxes

12.6

12.9

Other assets, net

133.6

132.9

Total assets

$             4,292.7

$               4,081.8

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:

Accounts payable

$               464.6

$                 438.0

Accrued expenses

301.5

374.2

Income taxes payable

63.4

46.4

Commercial paper

361.0

226.0

Current maturities of long-term debt

18.2

18.3

Current operating lease liabilities

83.8

88.9

Total current liabilities

1,292.5

1,191.8

Long-term debt

1,144.1

1,144.1

Long-term operating lease liabilities

347.8

293.4

Pensions

19.4

18.7

Other liabilities

275.0

270.7

Total liabilities

3,078.8

2,918.7

Commitments and contingencies

Stockholders' equity:

Preferred stock, $0.01 par value, 25,000,000 shares authorized, no shares issued
     or outstanding





Common stock, $0.01 par value, 200,000,000 shares authorized, 87,170,197
     shares issued

0.9

0.9

Additional paid-in capital

1,249.7

1,243.0

Retained earnings

4,963.0

4,891.1

Accumulated other comprehensive loss

(48.0)

(48.5)

Treasury stock, at cost, 52,360,280 shares and 52,374,147 shares for 2026 and
     2025, respectively

(4,951.7)

(4,923.4)

Total stockholders' equity

1,213.9

1,163.1

Total liabilities and stockholders' equity

$             4,292.7

$               4,081.8

LENNOX INTERNATIONAL INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(Amounts in millions)

For the Three Months
Ended March 31,

2026

2025

Cash flows from operating activities:

Net income

$            117.2

$            129.6

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

Loss (income) from equity method investments

0.4

(1.2)

Provision for credit losses

2.1

1.3

Unrealized losses (gains), net on derivative contracts

2.1

(0.5)

Stock-based compensation expense

6.3

6.3

Depreciation and amortization

29.2

25.6

Deferred income taxes

3.3

(1.1)

Pension expense

1.0

1.1

Pension contributions

(0.3)

(0.3)

Changes in assets and liabilities, net of effects of acquisitions and divestitures:

Accounts and notes receivable

(73.6)

8.3

Inventories

(62.6)

(209.4)

Other current assets

13.7

(1.7)

Accounts payable

31.0

85.2

Accrued expenses

(74.3)

(105.1)

Income taxes payable and receivable, net

18.8

27.1

Leases, net

1.3

3.4

Other, net

0.5

(4.4)

Net cash provided by (used in) operating activities

16.1

(35.8)

Cash flows from investing activities:

Proceeds from the disposal of property, plant and equipment

0.7

0.5

Purchases of property, plant and equipment

(55.5)

(25.5)

Acquisitions, net of cash

(0.2)



(Purchases of) proceeds from investments and other

(1.6)

1.5

Net cash used in investing activities

(56.6)

(23.5)

Cash flows from financing activities:

Commercial paper borrowings

434.1



Commercial paper payments

(299.1)



Payments on debt arrangements

(5.3)

(5.0)

Proceeds from employee stock purchases

2.6

1.2

Repurchases of common stock

(19.5)

(85.2)

Repurchases of common stock to satisfy employee withholding tax obligations

(10.5)

(11.3)

Cash dividends paid

(45.2)

(40.9)

Net cash provided by (used in) financing activities

57.1

(141.2)

Increase (decrease) in cash, cash equivalents and restricted cash

16.6

(200.5)

Effect of exchange rates on cash, cash equivalents and restricted cash equivalents

(2.1)

2.6

Cash, cash equivalents and restricted cash, beginning of period

52.7

415.1

Cash, cash equivalents and restricted cash, end of period

$             67.2

$            217.2

Supplemental disclosures of cash flow information:

Interest paid

$             23.5

$              19.2

Income taxes paid (net of refunds)

$              7.0

$               5.1

 Note: The 2025 amounts are adjusted to reflect the accounting method change from LIFO to FIFO that occurred in the fourth quarter of 2025.

LENNOX INTERNATIONAL INC. AND SUBSIDIARIES

Reconciliation to U.S. GAAP (Generally Accepted Accounting Principles) Measures

(Unaudited, in millions, except per share and ratio data)

Use of Non-GAAP Financial Measures

To supplement the Company's consolidated financial statements and segment net sales and profit (loss) presented in accordance with U.S. GAAP, additional non-GAAP financial measures are provided and reconciled in the following tables. The Company believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results and enhance the ability of investors to analyze the Company's business trends and operating performance.

Reconciliation of Net Cash Provided by (Used in) Operating Activities, a GAAP measure, to Free Cash Flow, a Non-
GAAP measure

For the Three Months
Ended March 31,

2026

2025

Net cash provided by (used in) operating activities

$            16.1

$         (35.8)

Purchases of property, plant and equipment

(55.5)

(25.5)

Proceeds from the disposal of property, plant and equipment

0.7

0.5

Free cash flow, a Non-GAAP measure

$           (38.7)

$         (60.8)

SOURCE Lennox International Inc.
2026-06-12 17:02 2mo ago
2026-04-29 09:30 4mo ago
Lennox International (LII) Surpasses Q1 Earnings and Revenue Estimates
LII Lennox International
FMP Stock News
Original source text
Lennox International (LII - Free Report) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.16 per share. This compares to earnings of $3.37 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +6.07%. A quarter ago, it was expected that this manufacturer of furnaces, air conditioners and other products would post earnings of $4.76 per share when it actually produced earnings of $4.45, delivering a surprise of -6.51%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Lennox, which belongs to the Zacks Building Products - Air Conditioner and Heating industry, posted revenues of $1.14 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 6.50%. This compares to year-ago revenues of $1.07 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Lennox shares have added about 2.1% since the beginning of the year versus the S&P 500's gain of 4.3%.

What's Next for Lennox?While Lennox has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Lennox was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $7.63 on $1.54 billion in revenues for the coming quarter and $24.25 on $5.5 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Building Products - Air Conditioner and Heating is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Aaon (AAON - Free Report) , has yet to report results for the quarter ended March 2026. The results are expected to be released on May 7.

This maker of air conditioning and heating equipment is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of -16.2%. The consensus EPS estimate for the quarter has been revised 2.7% lower over the last 30 days to the current level.

Aaon's revenues are expected to be $386.4 million, up 20% from the year-ago quarter.
2026-06-12 17:02 2mo ago
2026-04-29 10:30 4mo ago
Lennox (LII) Reports Q1 Earnings: What Key Metrics Have to Say
LII Lennox International
FMP Stock News
Original source text
Lennox International (LII - Free Report) reported $1.14 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 5.8%. EPS of $3.35 for the same period compares to $3.37 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.07 billion, representing a surprise of +6.5%. The company delivered an EPS surprise of +6.07%, with the consensus EPS estimate being $3.16.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Lennox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Building Climate Solutions: $485.1 million versus the 15-analyst average estimate of $418.43 million. The reported number represents a year-over-year change of +38.1%.Net Sales- Home Comfort Solutions: $650 million versus $646.23 million estimated by 15 analysts on average. Compared to the year-ago quarter, this number represents a -9.9% change.Segment Profit (loss)- Corporate and other: $-18.6 million versus the 14-analyst average estimate of $-17.88 million.Segment Profit (loss)- Building Climate Solutions: $95.6 million versus the 14-analyst average estimate of $77.89 million.Segment Profit (loss)- Home Comfort Solutions: $86.5 million versus $93.69 million estimated by 14 analysts on average.View all Key Company Metrics for Lennox here>>>

Shares of Lennox have returned +6.8% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-06-12 17:02 2mo ago
2026-04-29 15:11 4mo ago
Lennox International Inc. (LII) Q1 2026 Earnings Call Transcript
LII Lennox International
FMP Stock News
Original source text
Lennox International Inc. (LII) Q1 2026 Earnings Call Transcript
2026-06-12 17:02 2mo ago
2026-05-04 09:03 4mo ago
Lennox Opens 2026 Feel The Love® Nominations to Honor Community Heroes
LII Lennox International
FMP Stock News
Original source text
Nominations are now open for individuals who give back to their communities and need support replacing critical home comfort systems

, /PRNewswire/ -- Lennox (NYSE: LII), a leader in reliable home comfort solutions, today announced that nominations are open for the 2026 Feel The Love® program, sponsored by the LII Lennox Foundation. Through its trusted dealer network across the United States and Canada, Lennox will donate and professionally install new heating and cooling systems for individuals who are pillars of their communities and need dependable home comfort. Nominations are open through August 31, 2026, at FeelTheLove.com.

Lennox and Smith Services support H.A.L.O., a no‑kill animal shelter in Sebastian, Florida, through the Feel The Love® program by replacing an aging HVAC system and creating a safer, more comfortable environment for the animals and staff who care for them.

Lennox Feel the Love Logo (PRNewsfoto/Lennox International Inc.) "Feel The Love reflects who we are at Lennox, deeply committed to people, craftsmanship, and doing what's right," said Sarah Martin, EVP & President of Lennox Home Comfort Solutions. "Each nomination represents someone who consistently shows up for others. Alongside our dealer partners, we're proud to help bring reliable, high‑quality comfort to their homes."

Now in its 17th year, Feel The Love is a cornerstone of Lennox's community impact efforts. Since the program began in 2009, Lennox and its dealers have donated and installed more than 3,100 heating and cooling systems, helping homeowners facing significant challenges.

This year's Feel The Love Installation Week will take place October 3–11. During that time, selected recipients will receive up to a full heating and cooling system at no cost, including high-efficiency Lennox Merit equipment like air conditioners, heat pumps, furnaces, and thermostats, installed by local dealers who donate their time and expertise. Nominees include educators, veterans, healthcare professionals, first responders, caregivers, and families navigating unexpected medical or financial hardships. In addition, 501(c)(3) nonprofits are also accepted as Feel The Love program nominees (though they must be able to take residential HVAC equipment).

Community members are encouraged to submit nominations for individuals who put others first and would benefit from safe, reliable, and energy‑efficient home comfort. To learn more or submit a nomination, visit FeelTheLove.com. Updates throughout the program will be shared on Lennox's Facebook, Instagram, and LinkedIn channels.

About Lennox

Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information is available at www.lennox.com. Media inquiries may be directed to [email protected]. 

About Feel The Love®

Launched in 2009, Feel The Love is Lennox Residential HVAC's signature community-giving program. Each year, Lennox partners with local dealers and community members across the United States and parts of Canada to identify and support individuals who exemplify service to others and are in need of a helping hand. The LII Lennox Foundation proudly sponsors the Feel The Love program. Learn more at FeelTheLove.com.

SOURCE Lennox International Inc.
2026-06-12 17:02 2mo ago
2026-05-06 14:31 4mo ago
Lennox International Inc. (LII) Presents at Oppenheimer 21st Annual Industrial Growth Virtual Conference Transcript
LII Lennox International
FMP Stock News
Original source text
Lennox International Inc. (LII) Presents at Oppenheimer 21st Annual Industrial Growth Virtual Conference Transcript
2026-06-12 17:02 2mo ago
2026-05-21 11:48 3mo ago
Lennox Increases Quarterly Dividend
LII Lennox International
FMP Stock News
Original source text
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The board of directors at Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, approved an increase in the quarterly dividend from $1.30 to $1.36 per share of common stock, payable July 15, 2026, to stockholders of record as of June 30, 2026.

About Lennox
Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information is available at www.lennox.com.

Media Contact
[email protected]

Investor Relations Contact
[email protected]

SOURCE Lennox International Inc.

Also from this source
2026-06-12 17:02 2mo ago
2026-05-28 09:25 3mo ago
3 Stocks to Watch That Hiked Dividends Despite Economic Uncertainty
LII Lennox International
FMP Stock News
Original source text
Key Takeaways ALRS declared a $0.22 dividend payable July 10 and has raised payouts six times in five years.LII announced a $1.36 dividend for July 15, with a 1.03% yield and 23% payout ratio.ESEA declared a $0.80 dividend payable June 16 and currently offers a 4.59% dividend yield. Wall Street has remained volatile for most of the year despite all three major indexes hitting multiple all-time closing highs. High inflation, geopolitical tensions and labor market concerns have dented consumer confidence and have time and again unsettled markets.

Hopes of a rate cut by the Federal Reserve anytime soon are fast fading, and uncertainty over an end to the Iran war, which has resulted in a surge in global oil prices, continues to raise concerns.

Given the uncertainty, cautious investors looking for steady income and ways to protect their capital may consider holding or investing in dividend-paying stocks.

Such stocks provide steady earnings through regular dividend payouts and can help mitigate the effects of market volatility. Three such stocks are: Alerus Financial Corporation (ALRS - Free Report) , Lennon International Inc. (LII - Free Report) and Euroseas Ltd. (ESEA - Free Report) .

High Inflation, Geopolitical Tensions Dent Investors’ ConfidenceInflation has been on the rise over the past couple of months after easing in the first few months of the year. Inflation increased for the second consecutive month in April.

The consumer price index (CPI) jumped 0.6% in April following a 0.9% rise in March, according to data released by the Bureau of Labor Statistics. Compared to the same period last year, CPI rose 3.8% in April, reaching its highest annual level since May 2023.

Core CPI, which excludes the volatile food and energy categories, gained 0.4% from the previous month and increased 2.8% year over year. Much of April’s inflation growth was fueled by a 3.8% jump in energy costs, which accounted for nearly 40% of the total increase.

Oil prices have surged nearly 40% since the beginning of the Iran war. President Donald Trump announced a ceasefire last month, but there has been little progress on a peace deal after the first round of talks between the two warring nations failed.

On Wednesday night, the United States reportedly resumed its attack on Iran, raising fresh concerns over renewed tensions.

The Federal Reserve left interest rates unchanged in its current range of 3.5%-3.75% in its last meeting. However, the minutes of the Fed’s last FOMC show that several policymakers are in favor of a rate hike if inflation continues to remain above the 2% target.

3 Stocks That Recently Announced Dividend HikesAlerus Financial CorporationAlerus Financial Corporation is a financial services company. Through its subsidiary Alerus Financial, National Association, ALRS offers financial solutions to businesses and consumers. The company's segment consists of banking, retirement and benefit services, wealth management and mortgage. Alerus Financial Corporation has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

On May 22, Alerus Financial Corporation announced that its shareholders would receive a dividend of $0.22 a share on July 10. ALRS has a dividend yield of 2.91%. Over the past five years, Alerus Financial Corporation has increased its dividend six times, and its payout ratio presently sits at 27% of earnings. Check Alerus Financial Corporation’s dividend history here.

Lennon International Inc.Lennon International Inc. is a leading global provider of climate control solutions. LII designs, manufactures and markets a broad range of products for the heating, ventilation, air conditioning and refrigeration markets. Lennon International has a Zacks Rank #3.

On May 21, Lennon International declared that its shareholders would receive a dividend of $1.36 a share on July 15. LII has a dividend yield of 1.03%. Over the past five years, Lennon International has increased its dividend six times, and its payout ratio presently sits at 23% of earnings. Check Lennon International’s dividend history here.

Euroseas Ltd.Euroseas Ltd. has been in the shipping business for the past 136 years. ESEA operates in the dry cargo, drybulk and container shipping markets. Euroseas has a Zacks Rank #2.

On May 21, Euroseas Ltd announced that its shareholders would receive a dividend of $0.80 a share on June 16. ESEA has a dividend yield of 4.59%. Over the past five years, Euroseas Ltd has increased its dividend six times, and its payout ratio presently sits at 17% of earnings. Check Euroseas Ltd’s dividend history here.
2026-06-12 17:02 2mo ago
2026-06-03 08:54 3mo ago
Lennox Cold Climate Heat Pump Earns GOOD DESIGN® Recognition for Reliable Performance in Extreme Conditions
LII Lennox International
FMP Stock News
Original source text
Award highlights innovative design, dependable operation to -20°F, and lasting homeowner confidence

, /PRNewswire/ -- Lennox (NYSE: LII), a leader in energy-efficient building and home comfort solutions, today announced that its Dave Lennox Signature® Collection cold climate heat pump has received a GOOD DESIGN® Award, one of the world's most recognized honors for product design and innovation.

Presented by The Chicago Athenaeum: Museum of Architecture and Design in collaboration with Metropolitan Arts Press Ltd., the GOOD DESIGN® Award honors products that unite thoughtful design with lasting value, an approach that continues to guide Lennox's innovation.

The Dave Lennox Signature® Collection SL22KLV Cold Climate Heat Pump delivers precise, energy-efficient comfort in temperatures as low as -20°F, offering homeowners reliable performance and potential energy savings. The Lennox SL22KLV Cold Climate Heat Pump was engineered to deliver dependable, energy-efficient comfort in demanding winter environments, maintaining reliable operation in temperatures as low as -20°F. Designed for homeowners seeking comfort and confidence in extreme conditions, the system combines advanced heat pump technology with durable construction and precise system control.

"This recognition speaks to the diligence that goes into every Lennox innovation," said Prakash Bedapudi, EVP and Chief Technology Officer at Lennox. "From demanding cold weather performance to precise system control, this design reflects our commitment to helping homeowners feel confident in their decision, knowing they've chosen a durable solution built for long-term performance."

An integrated design approach supports lasting durability, from a robust cabinet engineered for durability to digital communication that enables accurate, consistent operation. Together, these features help ensure consistent performance in regions where winter conditions demand it most.

This latest GOOD DESIGN® recognition adds to Lennox's long history of award‑winning residential products, including the SL25XPV Heat Pump and the S40 Smart Thermostat, further demonstrating a commitment to solutions that are intuitive to operate, built to last, and designed to offer homeowners lasting peace of mind.

For more information about the SL22KLV Cold Climate Heat Pump, visit www.lennox.com.

About Lennox

Lennox (NYSE: LII) is a leader in energy-efficient building solutions and is committed to creating healthier and more comfortable environments. Serving residential and commercial customers, the company delivers innovative heating, cooling, indoor air quality, refrigeration, and water heating systems. Through trusted products, parts, and services, and advanced technology, Lennox delivers connected solutions that support the full lifecycle of customer needs. Additional information is available at www.lennox.com. Media inquiries may be directed to [email protected].

SOURCE Lennox International Inc.
2026-06-12 17:02 2mo ago
2026-06-03 09:00 3mo ago
Lennox Cold Climate Heat Pump Earns GOOD DESIGN® Recognition for Reliable Performance in Extreme Conditions
LII Lennox International
FMP Stock News
Original source text
Lennox Cold Climate Heat Pump Earns GOOD DESIGNÂ Recognition for Reliable Performance in Extreme Conditions PR Newswire
2026-06-12 17:02 2mo ago
2026-06-03 13:21 3mo ago
Lennox International Inc. (LII) Presents at 46th Annual William Blair Growth Stock Conference Transcript
LII Lennox International
FMP Stock News
Original source text
Lennox International Inc. (LII) Presents at 46th Annual William Blair Growth Stock Conference Transcript
2026-06-12 17:02 2mo ago
2026-03-13 11:11 5mo ago
Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise?
ACLX Arcellx
FMP Stock News
Original source text
Key Takeaways Gilead cell therapy sales fell 7% to $1.8B in 2025 as Yescarta and Tecartus faced growing competition.GILD will acquire Arcellx for $7.8B, gaining control of anito-cel, eliminating profit-sharing and royalties.GILD expects an FDA decision on anito-cel for relapsed or refractory multiple myeloma in Dec. 2026. Gilead Sciences, Inc.’s (GILD - Free Report) Cell Therapy franchise currently comprises Yescarta and Tecartus. Sales from this unit decreased 7% year over year to $1.8 billion (in 2025) due to ongoing competitive headwinds.

Yescarta sales decreased 5% year over year to $1.5 billion, primarily as a result of in- and out-of-class competition.

Tecartus sales decreased 15% to $344 million due to in-class competition.

GILD anticipates competitive pressure in cell therapies’ business to continue in 2026, including new market entrants in several countries outside the United States.

In a move to combat this decline, Gilead recently announced that it will acquire a clinical-stage biotechnology company, Arcellx , for $115 per share in cash plus a $5 contingent value right, implying an equity value of $7.8 billion.

Gilead’s subsidiary, Kite, already has a collaboration to co-develop and co-commercialize Arcellx’s lead pipeline candidate, anitocabtagene autoleucel (anito-cel).

A biologics license application seeking approval of anito-cel as a fourth-line treatment for patients with relapsed or refractory multiple myeloma has been accepted by the FDA, with a PDUFA decision expected in December 2026, providing a near-term commercial catalyst and potential expansion into earlier treatment settings.

Beyond anito-cel, Arcellx’s proprietary D-Domain platform provides long-term strategic value for next-generation CAR-T and in vivo cell therapies.

The acquisition gives GILD full control of anito-cel, streamlining development and commercialization economics by eliminating profit-sharing, milestone payments and royalties, thereby enhancing long-term margin potential and value capture.

The acquisition, expected to be closed in the second quarter of 2026, is projected to be earnings accretive from 2028.

While GILD has a dominant HIV franchise led by flagship HIV therapies — Biktarvy for treatment and Descovy for prevention — it is looking to ramp up its oncology franchise and diversify its revenue base.

Competition for GILD in the Cell Therapy SpaceBiotech giant Bristol Myers (BMY - Free Report) has a strong cell-therapy portfolio with therapies like Breyanzi and Abecma.

Breyanzi (lisocabtagene maraleucel) is a CAR T cell therapy developed for the treatment of relapsed or refractory large B-cell lymphoma, chronic lymphocytic leukemia, follicular lymphoma and mantle cell lymphoma.

Breyanzi surpassed $1 billion in annualized sales in 2025, reflecting adoption in large B-cell lymphoma and recent label expansions. The strong uptake of Breyanzi boosted BMY’s top line.

Another approved CAR T therapy is Novartis’ (NVS - Free Report) Kymriah, which is approved for acute lymphoblastic leukemia that is either relapsing or refractory. It is also used in patients with LBCL or FL, two types of non-Hodgkin lymphoma, who have relapsed or are refractory after having at least two other kinds of treatment.

NVS’ Kymriah recorded sales of $381 million in 2025, down 14% from 2024 due to competitive pressure.

NVS is also developing another CAR T cell therapy, YTB323, for LBCL.

GILD’s Price Performance, Valuation and EstimatesShares of GILD have surged 30.3% in the past year compared with the industry’s growth of 15.4%.

Image Source: Zacks Investment Research

Going by the price/earnings ratio, GILD’s shares currently trade at 16.41x forward earnings, higher than its mean of 11.32x but lower than 17.89x for the large-cap pharma industry.

Image Source: Zacks Investment Research

The bottom-line estimate for 2026 has moved up to $8.66 from $8.60 in the past 30 days, while that for 2027 has moved north to $9.63 from $9.33 in the same time frame.

Image Source: Zacks Investment Research
2026-06-12 17:02 2mo ago
2026-03-13 16:06 5mo ago
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
ACLX Arcellx
FMP Stock News
Original source text
-

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Arcellx, Inc. (NasdaqGS: ACLX) to Gilead Sciences, Inc. (NasdaqGS: GILD). Under the terms of the proposed transaction, shareholders of Arcellx will receive $115.00 per share in cash plus one contingent value right of $5.00 per share upon the achievement of certain milestones. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-aclx/ to learn more.

Please note that the transaction is structured as a tender offer, such that time may be of the essence.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

More News From Kahn Swick & Foti, LLC

Back to Newsroom
2026-06-12 17:02 2mo ago
2026-03-16 04:22 5mo ago
Bamco Inc. NY Has $45.17 Million Stake in Arcellx, Inc. $ACLX
ACLX Arcellx
FMP Stock News
Original source text
Bamco Inc. NY lifted its holdings in Arcellx, Inc. (NASDAQ: ACLX) by 6.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 550,236 shares of the company's stock after acquiring an additional 32,227 shares during the quarter. Bamco Inc. NY owned
2026-06-12 17:02 2mo ago
2026-03-16 11:00 5mo ago
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?
ACLX Arcellx
FMP Stock News
Original source text
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Masimo Corporation (NASDAQ: MASI)'s sale to Danaher Corporation for $180.00 per share in cash. If you are a Masimo shareholder, click here to learn more about your legal rights and options.

Arcellx, Inc. (NASDAQ: ACLX)'s sale to Gilead Sciences, Inc. for $115.00 per share in cash plus one contingent value right of $5.00 per share upon the achievement of certain milestones. If you are an Arcellx shareholder, click here to learn more about your legal rights and options.

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD)'s sale to Saltchuk Resources, Inc. for $17.00 per share in cash. If you are a Great Lakes shareholder, click here to learn more about your rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP
2026-06-12 17:02 2mo ago
2026-03-16 19:13 5mo ago
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
ACLX Arcellx
FMP Stock News
Original source text
On February 17, 2026, Cormorant Asset Management disclosed in a regulatory filing that it sold its entire stake in Arcellx (ACLX +0.00%), an estimated $63.63 million transaction based on last-disclosed position values.

What happenedAccording to an SEC filing dated February 17, 2026, Cormorant Asset Management sold 775,000 shares of Arcellx, fully liquidating its position. The quarter-end value of the fund’s Arcellx stake declined by $63.63 million as a result of the exit.

What else to knowThe fund’s sale of Arcellx reduced its position from 4.4% of 13F reportable AUM in the previous quarter to zero.Top holdings after the filing:NASDAQ:PRAX: $280.00 million (15.9% of AUM)NASDAQ:BBOT: $223.84 million (12.7% of AUM)NASDAQ:ABVX: $182.05 million (10.3% of AUM)NASDAQ:EYPT: $151.00 million (8.6% of AUM)NASDAQ:RAPP: $91.85 million (5.2% of AUM)As of Monday, Arcellx shares were priced at $114.51, up a staggering 60% over the past year and well outperforming the S&P 500’s roughly 19% gain in the same period.Company overviewMetricValuePrice (as of Monday)$114.51Market capitalization$6.7 billionRevenue (TTM)$22.3 millionNet income (TTM)($228.9 million)Company snapshotArcellx develops immunotherapies targeting cancer and incurable diseases, with lead candidates including CART-ddBCMA for multiple myeloma and pipeline assets for AML, MDS, and solid tumors.The company operates as a clinical-stage biotechnology company focused on research and development of cell-based therapies.It serves healthcare providers and research institutions seeking advanced oncology and hematology treatments for relapsed or refractory patient populations.Arcellx is advancing proprietary ddCAR and ARC-T cell platforms to address high unmet medical needs in relapsed or refractory cancers. The company’s pipeline includes multiple candidates targeting both hematologic malignancies and solid tumors.

What this transaction means for investorsArcellx shares are up 80% this year, and there’s one clear catalyst for that move. The company has been developing next-generation CAR-T cell therapies designed to treat cancers such as multiple myeloma. Its lead therapy, anitocabtagene autoleucel, has shown strong clinical responses and attracted the attention of larger pharmaceutical companies eager to expand their oncology pipelines.

That interest ultimately culminated in a takeover agreement from Gilead Sciences last month, valuing Arcellx at about $7.8 billion and offering shareholders $115 per share in cash plus a potential additional payment tied to future sales milestones. The deal builds on an existing 2022 collaboration between the two companies around the therapy and could accelerate development and commercialization if regulatory approvals move forward.

Still, it’s important to note this pop happened after Cormorant’s reported exit, a reminder that even smart investments can miss out due to timing flukes. What ultimately matters more is identifying companies building therapies that larger industry players ultimately want to own.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-06-12 17:02 2mo ago
2026-03-19 14:02 5mo ago
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?
ACLX Arcellx
FMP Stock News
Original source text
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Arcellx, Inc. (NASDAQ: ACLX)'s sale to Gilead Sciences, Inc. for $115.00 per share in cash plus one contingent value right of $5.00 per share upon the achievement of certain milestones. If you are an Arcellx shareholder, click here to learn more about your legal rights and options.

Masimo Corporation (NASDAQ: MASI)'s sale to Danaher Corporation for $180.00 per share in cash. If you are a Masimo shareholder, click here to learn more about your legal rights and options.

FONAR Corporation (NASDAQ: FONR)'s sale to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company for $19.00 per share for FONAR's Class B common stock and $6.34 per share for FONAR's Class C common stock. If you are a FONAR shareholder, click here to learn more about your legal rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP
2026-06-12 17:02 2mo ago
2026-04-01 16:13 5mo ago
Gilead Extends Tender Offer to Acquire Arcellx
ACLX Arcellx
FMP Stock News
Original source text
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx. The offer remains at a purchase price of (1) $115.00 per share, net to the seller in cash, without interest, subject to any withholding tax, plus (2) one contractual contingent value right (CVR), which represents the right to receive one contingent payment of $5.00 per CVR in cash, without interest, and subject to any withholding tax, payable on March 31, 2030, subject to cumulative worldwide sales of Arcellx’s anitocabtagene autoleucel (anito-cel) product exceeding $6.0 billion on or prior to December 31, 2029.

The tender offer, which was previously scheduled to expire at one minute after 11:59 p.m., Eastern Time, on April 2, 2026, has been extended to expire at 5:00 p.m., Eastern Time, on April 24, 2026. The transaction is anticipated to close during the second quarter of 2026, subject to the satisfaction or waiver of customary closing conditions, including the tender of a number of shares of Arcellx common stock that, together with shares already owned by Gilead, equals at least a majority of the then-outstanding Arcellx shares, the receipt of regulatory approvals and other customary offer conditions.

Computershare Trust Company, N.A., the depositary and paying agent for the tender offer, has advised Gilead that, as of 5:00 p.m., Eastern Time, on March 31, 2026, approximately 4,389,763 shares have been validly tendered and not validly withdrawn in the tender offer, representing approximately 7.5% of the outstanding shares as of such date and time. Holders that have previously tendered their shares do not need to re-tender their shares or take any other action in response to the extension of the tender offer. Questions or requests for assistance may be directed to Innisfree M&A Incorporated, the information agent for the tender offer, by calling toll free (877) 800-5182.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness – while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.

Forward-Looking Statements

This communication contains forward-looking statements related to Gilead, Arcellx and the acquisition of Arcellx by Gilead that are subject to risks, uncertainties, and other factors. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including all statements regarding the intent, belief or current expectation of Gilead and Arcellx and members of their respective senior management teams. In some cases, forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “seek,” “may,” “plan,” “project,” “should,” “target,” “will,” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, without limitation, statements regarding the transaction and related matters, prospective performance and opportunities, post-closing operations and the outlook for the companies’ businesses, including, without limitation, filings and approvals relating to the transaction; the expected timing of the completion of the transaction; the ability to satisfy the various closing conditions and complete the transaction; and any assumptions underlying any of the foregoing. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties that could cause the actual results to differ from expectations contemplated by forward-looking statements include: uncertainties as to the timing of the tender offer and merger; uncertainties as to how many of Arcellx’s stockholders will tender their stock in the offer; the possibility that competing offers will be made; the possibility that various closing conditions for the transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction; the effects of the transaction on relationships with employees, other business partners or governmental entities; the difficulty of predicting the timing or outcome of regulatory approvals or actions, if any; the risk that, if the transaction is consummated, the businesses will not be integrated successfully and that other anticipated benefits from the transaction will not be realized; any negative effects on the existing collaboration between Arcellx and Gilead that may result from the announcement of a transaction, or the failure to complete the transaction; the risk that the milestone associated with the CVR may not be achieved and that holders of CVRs may not receive payments in respect thereof; the impact of competitive products and pricing; other business effects, including the effects of industry, economic or political conditions outside of the companies’ control; transaction costs; actual or contingent liabilities; and other risks and uncertainties detailed from time to time in the companies’ periodic reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, as well as the Schedule 14D-9 filed by Arcellx and the Schedule TO and related tender offer documents filed by Gilead and Ravens Sub, Inc. (“Purchaser”), a wholly owned subsidiary of Gilead. All forward-looking statements are based on information currently available to Gilead, and Gilead assume no obligation and disclaim any intent to update any such forward-looking statements.

Additional Information and Where to Find It

In connection with the proposed acquisition of Arcellx, Gilead caused Purchaser to commence a tender offer to purchase all of the outstanding shares of common stock of Arcellx. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities of Arcellx, nor is it a substitute for any tender offer materials that Gilead, Ravens Sub, Inc. or Arcellx has filed or will file with the SEC. A solicitation and an offer to buy securities of Arcellx is being made only pursuant to an offer to purchase and related materials that Gilead has filed with the SEC. Gilead has filed a Tender Offer Statement on Schedule TO with the SEC, and Arcellx has filed a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the tender offer. ARCELLX’S STOCKHOLDERS AND OTHER INVESTORS ARE URGED TO READ THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT SHOULD BE READ CAREFULLY BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER OFFER. The Offer to Purchase, the related letter of transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement on Schedule 14D-9, have been sent to all stockholders of Arcellx at no expense to them. The Tender Offer Statement on Schedule TO, the Solicitation/Recommendation Statement on Schedule 14D-9 and other related documents are made available for free at the SEC’s web site at www.sec.gov. Additional copies may be obtained for free by contacting Gilead or Arcellx. Free copies of these materials and certain other offering documents are available from Gilead by mail to Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, attention: Investor Relations, by phone at 1-800-GILEAD-5 or 1-650-574-3000, or by directing requests for such materials to the information agent for the offer. Investors and security holders of Arcellx may also obtain, free of charge, the Solicitation/Recommendation Statement on Schedule 14D-9 and other related documents that the Company has filed with or furnished to the SEC under the “Financials” section of Arcellx’s website at https://ir.arcellx.com/financials/sec-filings/default.aspx.

In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, Gilead and Arcellx file annual, quarterly and current reports, proxy statements and other information with the SEC. Gilead’s and Arcellx’s filings with the SEC are also available for free to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov.

Gilead, Kite, and the Gilead logo are trademarks of Gilead Sciences, Inc., or its related companies.

More News From Gilead Sciences, Inc.
2026-06-12 17:02 2mo ago
2026-04-04 03:44 5mo ago
Banque Pictet & Cie SA Acquires Shares of 5,109 Arcellx, Inc. $ACLX
ACLX Arcellx
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 4th, 2026

Banque Pictet & Cie SA bought a new stake in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 5,109 shares of the company’s stock, valued at approximately $333,000.

Several other large investors also recently modified their holdings of the stock. MAI Capital Management bought a new position in Arcellx in the 3rd quarter valued at about $26,000. CWM LLC increased its stake in Arcellx by 267.0% in the third quarter. CWM LLC now owns 345 shares of the company’s stock valued at $28,000 after acquiring an additional 251 shares during the last quarter. State of Wyoming bought a new position in Arcellx in the second quarter valued at approximately $28,000. Ramirez Asset Management Inc. acquired a new position in Arcellx during the third quarter valued at approximately $41,000. Finally, Abich Financial Wealth Management LLC acquired a new position in Arcellx during the third quarter valued at approximately $62,000. 96.03% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades A number of equities research analysts have weighed in on the company. Guggenheim downgraded Arcellx from a “buy” rating to a “neutral” rating and reduced their target price for the company from $120.00 to $115.00 in a report on Wednesday, February 25th. TD Cowen cut Arcellx from a “strong-buy” rating to a “hold” rating in a report on Monday, March 2nd. Truist Financial upgraded Arcellx from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 20th. Canaccord Genuity Group set a $115.00 price objective on Arcellx in a research note on Monday, February 23rd. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $115.00 target price (down from $127.00) on shares of Arcellx in a research report on Monday, February 23rd. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, sixteen have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $111.87.

Get Our Latest Analysis on ACLX

Insider Activity at Arcellx In other Arcellx news, insider Christopher Heery sold 7,437 shares of the business’s stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $65.51, for a total transaction of $487,197.87. Following the sale, the insider directly owned 29,631 shares of the company’s stock, valued at $1,941,126.81. The trade was a 20.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Rami Elghandour sold 89,916 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $113.92, for a total transaction of $10,243,230.72. Following the completion of the transaction, the insider owned 276,051 shares of the company’s stock, valued at approximately $31,447,729.92. This trade represents a 24.57% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 109,366 shares of company stock valued at $11,526,708 in the last ninety days. 8.35% of the stock is currently owned by insiders.

Arcellx Stock Performance Shares of ACLX opened at $114.77 on Friday. Arcellx, Inc. has a 52 week low of $47.86 and a 52 week high of $114.94. The stock has a market capitalization of $6.71 billion, a price-to-earnings ratio of -28.20 and a beta of 0.25. The stock has a fifty day moving average of $95.96 and a 200-day moving average of $83.63.

Arcellx (NASDAQ:ACLX – Get Free Report) last issued its quarterly earnings data on Thursday, February 26th. The company reported ($1.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($1.01). The business had revenue of $1.65 million for the quarter, compared to analyst estimates of $13.40 million. Arcellx had a negative return on equity of 55.42% and a negative net margin of 1,027.26%. As a group, equities analysts forecast that Arcellx, Inc. will post -1.58 EPS for the current year.

Arcellx Company Profile (Free Report)

Arcellx, Inc (NASDAQ: ACLX) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of next-generation cell therapies for oncology and autoimmune diseases. The company’s proprietary ARC-SparX™ platform is designed to enable precise control over cell-surface receptor activation and to improve the safety, efficacy and durability of adoptive cell therapies. Leveraging this technology, Arcellx engineers immune cells with modular antigen-binding domains that can be exchanged to target a variety of disease-associated markers.

The company’s pipeline comprises multiple wholly owned programs in hematologic malignancies and solid tumors at various stages of preclinical and clinical development.

Featured Articles Five stocks we like better than Arcellx

Receive News & Ratings for Arcellx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcellx and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBanque Pictet & Cie SA Has $287,000 Stake in iShares U.S. Regional Banks ETF $IAT

NEXT HEADLINE »Regions Financial Corporation $RF Shares Acquired by American National Bank & Trust
2026-06-12 17:02 2mo ago
2026-04-17 08:30 4mo ago
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
ACLX Arcellx
FMP Stock News
Original source text
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all required regulatory approvals have been obtained for its previously announced acquisition of Arcellx and that Gilead has extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx.

On April 13, 2026, the Australian Competition and Consumer Commission (ACCC) published its decision that the acquisition of Arcellx may be put into effect, subject to expiration of a 14-calendar day waiting period. Assuming that the ACCC’s determination remains unchallenged during this waiting period, the waiting period expires at 10:00 a.m., Eastern Time, on April 27, 2026. Additionally, the relevant review period for the Austrian competition authorities has expired. Accordingly, all required regulatory approvals for the transaction have been obtained, and the “Regulatory Approvals Condition” (as defined in the Offer to Purchase, dated March 6, 2026, relating to the offer) will be satisfied upon expiration of the 14-calendar day review period pursuant to Australian competition law.

The tender offer, which was previously scheduled to expire at 5:00 p.m., Eastern Time, on April 24, 2026, has been extended to expire at 5:00 p.m., Eastern Time, on April 27, 2026, and remains subject to the satisfaction or waiver of customary closing conditions, including the tender of a number of shares of Arcellx common stock that, together with shares already owned by Gilead, equals at least a majority of the then-outstanding Arcellx shares and other customary offer conditions.

The offer remains at a purchase price of (1) $115.00 per share, net to the seller in cash, without interest, subject to any withholding tax, plus (2) one contractual contingent value right (CVR), which represents the right to receive one contingent payment of $5.00 per CVR in cash, without interest, and subject to any withholding tax, payable on March 31, 2030, subject to cumulative worldwide sales of Arcellx’s anitocabtagene autoleucel (anito-cel) product exceeding $6.0 billion on or prior to December 31, 2029.

Computershare Trust Company, N.A., the depositary and paying agent for the tender offer, has advised Gilead that, as of 4:00 p.m., Eastern Time, on April 16, 2026, approximately 10,271,823 shares have been validly tendered and not validly withdrawn in the tender offer, representing approximately 17.5% of the outstanding shares as of such date and time. Holders that have previously tendered their shares do not need to re-tender their shares or take any other action in response to the extension of the tender offer. Questions or requests for assistance may be directed to Innisfree M&A Incorporated, the information agent for the tender offer, by calling toll free (877) 800-5182.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness – while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.

Forward-Looking Statements

This communication contains forward-looking statements related to Gilead, Arcellx and the acquisition of Arcellx by Gilead that are subject to risks, uncertainties, and other factors. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including all statements regarding the intent, belief or current expectation of Gilead and Arcellx and members of their respective senior management teams. In some cases, forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “seek,” “may,” “plan,” “project,” “should,” “target,” “will,” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, without limitation, statements regarding the transaction and related matters, prospective performance and opportunities, post-closing operations and the outlook for the companies’ businesses, including, without limitation, filings and approvals relating to the transaction; the expected timing of the completion of the transaction; the ability to satisfy the various closing conditions and complete the transaction; and any assumptions underlying any of the foregoing. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties that could cause the actual results to differ from expectations contemplated by forward-looking statements include: uncertainties as to the timing of the tender offer and merger; uncertainties as to how many of Arcellx’s stockholders will tender their stock in the offer; the possibility that competing offers will be made; the possibility that various closing conditions for the transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction; the effects of the transaction on relationships with employees, other business partners or governmental entities; the difficulty of predicting the timing or outcome of regulatory approvals or actions, if any; the risk that, if the transaction is consummated, the businesses will not be integrated successfully and that other anticipated benefits from the transaction will not be realized; any negative effects on the existing collaboration between Arcellx and Gilead that may result from the announcement of a transaction, or the failure to complete the transaction; the risk that the milestone associated with the CVR may not be achieved and that holders of CVRs may not receive payments in respect thereof; the impact of competitive products and pricing; other business effects, including the effects of industry, economic or political conditions outside of the companies’ control; transaction costs; actual or contingent liabilities; and other risks and uncertainties detailed from time to time in the companies’ periodic reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, as well as the Schedule 14D-9 filed by Arcellx and the Schedule TO and related tender offer documents filed by Gilead and Ravens Sub, Inc. (“Purchaser”), a wholly owned subsidiary of Gilead. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation and disclaims any intent to update any such forward-looking statements.

Additional Information and Where to Find It

In connection with the proposed acquisition of Arcellx, Gilead caused Purchaser to commence a tender offer to purchase all of the outstanding shares of common stock of Arcellx. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities of Arcellx, nor is it a substitute for any tender offer materials that Gilead, Ravens Sub, Inc. or Arcellx has filed or will file with the SEC. A solicitation and an offer to buy securities of Arcellx is being made only pursuant to an offer to purchase and related materials that Gilead has filed with the SEC. Gilead has filed a Tender Offer Statement on Schedule TO with the SEC, and Arcellx has filed a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the tender offer. ARCELLX’S STOCKHOLDERS AND OTHER INVESTORS ARE URGED TO READ THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT SHOULD BE READ CAREFULLY BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER OFFER. The Offer to Purchase, the related letter of transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement on Schedule 14D-9, have been sent to all stockholders of Arcellx at no expense to them. The Tender Offer Statement on Schedule TO, the Solicitation/Recommendation Statement on Schedule 14D-9 and other related documents are made available for free at the SEC’s website at www.sec.gov. Additional copies may be obtained for free by contacting Gilead or Arcellx. Free copies of these materials and certain other offering documents are available from Gilead by mail to Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, attention: Investor Relations, by phone at 1-800-GILEAD-5 or 1-650-574-3000, or by directing requests for such materials to the information agent for the offer. Investors and security holders of Arcellx may also obtain, free of charge, the Solicitation/Recommendation Statement on Schedule 14D-9 and other related documents that Arcellx has filed with or furnished to the SEC under the “Financials” section of Arcellx’s website at https://ir.arcellx.com/financials/sec-filings/default.aspx.

In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, Gilead and Arcellx file annual, quarterly and current reports, proxy statements and other information with the SEC. Gilead’s and Arcellx’s filings with the SEC are also available for free to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov.

Gilead, Kite, and the Gilead logo are trademarks of Gilead Sciences, Inc., or its related companies.

More News From Gilead Sciences, Inc.
2026-06-12 17:02 2mo ago
2026-04-24 02:12 4mo ago
Arcellx, Inc. (NASDAQ:ACLX) Given Consensus Recommendation of “Hold” by Analysts
ACLX Arcellx
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 24th, 2026

Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) has been given an average rating of “Hold” by the nineteen research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, sixteen have issued a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $111.8667.

A number of equities research analysts recently commented on ACLX shares. Wells Fargo & Company downgraded Arcellx from an “overweight” rating to an “equal weight” rating and set a $115.00 target price on the stock. in a research report on Monday, February 23rd. Rothschild & Co Redburn cut shares of Arcellx from a “buy” rating to a “neutral” rating and set a $82.00 price target on the stock. in a research report on Thursday, February 12th. UBS Group lowered shares of Arcellx from a “buy” rating to a “neutral” rating and increased their price objective for the company from $100.00 to $115.00 in a research report on Tuesday, February 24th. Needham & Company LLC downgraded shares of Arcellx from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Finally, Truist Financial upgraded shares of Arcellx from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 20th.

Get Our Latest Report on Arcellx

Insider Buying and Selling In related news, insider Rami Elghandour sold 89,916 shares of Arcellx stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $113.92, for a total value of $10,243,230.72. Following the completion of the transaction, the insider owned 276,051 shares in the company, valued at approximately $31,447,729.92. This trade represents a 24.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 8.35% of the company’s stock.

Institutional Inflows and Outflows Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MAI Capital Management purchased a new position in Arcellx in the third quarter worth about $26,000. CWM LLC increased its position in Arcellx by 267.0% during the third quarter. CWM LLC now owns 345 shares of the company’s stock valued at $28,000 after acquiring an additional 251 shares during the last quarter. State of Wyoming bought a new position in Arcellx during the second quarter valued at $28,000. Ramirez Asset Management Inc. bought a new position in Arcellx during the third quarter valued at $41,000. Finally, Abich Financial Wealth Management LLC bought a new position in Arcellx during the third quarter valued at $62,000. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Arcellx Trading Up 0.0% Shares of ACLX stock opened at $115.05 on Friday. The stock has a market capitalization of $6.73 billion, a price-to-earnings ratio of -28.27 and a beta of 0.25. Arcellx has a 12-month low of $47.86 and a 12-month high of $115.13. The stock’s 50-day moving average price is $108.95 and its 200-day moving average price is $87.05.

Arcellx (NASDAQ:ACLX – Get Free Report) last posted its earnings results on Thursday, February 26th. The company reported ($1.01) EPS for the quarter, hitting analysts’ consensus estimates of ($1.01). The company had revenue of $1.65 million for the quarter, compared to the consensus estimate of $13.40 million. Arcellx had a negative return on equity of 55.42% and a negative net margin of 1,027.26%. As a group, research analysts predict that Arcellx will post -2.91 EPS for the current fiscal year.

About Arcellx (Get Free Report)

Arcellx, Inc (NASDAQ: ACLX) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of next-generation cell therapies for oncology and autoimmune diseases. The company’s proprietary ARC-SparX™ platform is designed to enable precise control over cell-surface receptor activation and to improve the safety, efficacy and durability of adoptive cell therapies. Leveraging this technology, Arcellx engineers immune cells with modular antigen-binding domains that can be exchanged to target a variety of disease-associated markers.

The company’s pipeline comprises multiple wholly owned programs in hematologic malignancies and solid tumors at various stages of preclinical and clinical development.

Featured Stories Five stocks we like better than Arcellx

Receive News & Ratings for Arcellx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcellx and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINESeacoast Banking Corporation of Florida (NASDAQ:SBCF) Receives Average Rating of “Hold” from Analysts

NEXT HEADLINE »Dime Community Bancshares (NASDAQ:DCOM) & Community Capital Bancshares (OTCMKTS:ALBY) Head-To-Head Survey
2026-06-12 17:02 2mo ago
2026-04-27 10:45 4mo ago
Are Medical Stocks Lagging Arcellx (ACLX) This Year?
ACLX Arcellx
FMP Stock News
Original source text
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Arcellx, Inc. been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Arcellx, Inc. is one of 890 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Arcellx, Inc. is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for ACLX's full-year earnings has moved 1.5% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the most recent data, ACLX has returned 76.4% so far this year. Meanwhile, stocks in the Medical group have lost about 8% on average. This means that Arcellx, Inc. is outperforming the sector as a whole this year.

Astellas Pharma Inc. (ALPMY - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 16.1%.

Over the past three months, Astellas Pharma Inc.'s consensus EPS estimate for the current year has increased 15.2%. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Arcellx, Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 435 individual stocks and currently sits at #94 in the Zacks Industry Rank. On average, this group has lost an average of 0.7% so far this year, meaning that ACLX is performing better in terms of year-to-date returns.

On the other hand, Astellas Pharma Inc. belongs to the Medical - Drugs industry. This 133-stock industry is currently ranked #78. The industry has moved -0.8% year to date.

Arcellx, Inc. and Astellas Pharma Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.
2026-06-12 17:02 2mo ago
2026-04-28 08:45 4mo ago
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
ACLX Arcellx
FMP Stock News
Original source text
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX). Under the terms of the transaction, Gilead acquired Arcellx for $115 per share in cash, plus one non‑transferable contingent value right (CVR) of $5 per share, representing a total implied equity value of approximately $7.8 billion at the time of closing.

The acquisition builds on Kite, a Gilead Company, and Arcellx’s successful collaboration and provides Gilead with full control of anitocabtagene autoleucel (anito‑cel), an investigational BCMA‑directed CAR T‑cell therapy for multiple myeloma. By consolidating ownership of anito‑cel and eliminating future profit‑share, milestone and royalty obligations, Gilead is positioned to accelerate development, streamline decision‑making and maximize the long‑term potential of the program.

“With the Arcellx acquisition, our focus turns to executing with speed and discipline as we prepare to bring anito‑cel to patients,” said Cindy Perettie, Executive Vice President and Global Head of Kite. “I want to thank the Arcellx team for their scientific leadership, close collaboration to date and deep expertise they bring as we advance anito‑cel. With this acquisition, anito‑cel and the differentiated D‑Domain BCMA binder will advance within Kite, combining this science with our global manufacturing, regulatory and commercial capabilities to unlock the full value of this potentially transformative therapy for people living with multiple myeloma.”

On April 28, 2026, Gilead successfully completed its tender offer for all outstanding shares of common stock of Arcellx and accepted for payment all shares validly tendered and not validly withdrawn as of the expiration time of the tender offer, which shares represented, together with shares already owned by Gilead, approximately 77.2% of Arcellx’s outstanding shares. Following completion of the offer, Gilead completed the acquisition of Arcellx through a merger of Gilead’s wholly owned subsidiary with and into Arcellx, in which shares of Arcellx common stock were cancelled and converted into the right to receive the same $115 per share in cash and one CVR of $5 per share as shares tendered in the offer.

The CVR is payable upon achievement of cumulative global net sales of anito‑cel of at least $6.0 billion from launch through the end of 2029.

As a result of the completion of the merger, Arcellx has become a wholly owned subsidiary of Gilead and the common stock of Arcellx will be delisted from the Nasdaq Global Select Market.

This transaction is expected to be accounted for as an asset acquisition and reduce Gilead’s GAAP and non-GAAP 2026 diluted EPS by approximately $5.57 - $5.67. Excluding the impact of acquired in-process research and development expenses, Gilead expects the transaction to be modestly dilutive to earnings per share in 2026 and 2027, and accretive in 2028 and thereafter, subject to FDA approval of anito‑cel.

About Anito-cel

Anitocabtagene autoleucel (anito-cel, previously ddBCMA) is the first BCMA-directed CAR T-cell therapy to be investigated in multiple myeloma that utilizes a novel and compact binder known as the D-Domain. The small, stable D-Domain binder enables high CAR expression without tonic signaling and is designed to quickly release from the BCMA target. This combination may allow for the effective elimination of multiple myeloma cells without severe immunotoxicity. Anito-cel has been granted Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy Designations by the U.S. Food and Drug Administration.

About Gilead and Kite Oncology

Gilead and Kite Oncology are working to transform how cancer is treated. We are innovating with next-generation therapies, combinations and technologies to deliver improved outcomes for people with cancer. We are purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. From antibody-drug conjugate technologies and small molecules to cell therapy-based approaches, we are creating new possibilities for people with cancer.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness – while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.

Forward-Looking Statements

This communication contains forward-looking statements related to Gilead, Arcellx and the acquisition of Arcellx by Gilead that are subject to risks, uncertainties, and other factors. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including all statements regarding the intent, belief or current expectation of Gilead and Arcellx and members of their respective senior management teams. In some cases, forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “seek,” “may,” “plan,” “project,” “should,” “target,” “will,” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, without limitation, statements regarding the transaction and related matters, prospective performance and opportunities, post-closing operations and the outlook for the companies’ businesses, including Gilead’s ability to apply its global manufacturing, regulatory and commercial capabilities and to accelerate the development of anito-cel; regulatory applications; the potential of Arcellx’s cell therapy platform; the impact of the transaction on Gilead’s diluted EPS; and any assumptions underlying any of the foregoing. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties that could cause the actual results to differ from expectations contemplated by forward-looking statements include: the effects of the transaction on relationships with employees, other business partners or governmental entities; the difficulty of predicting the timing or outcome of regulatory approvals or actions, if any; the risk that the businesses will not be integrated successfully and that other anticipated benefits from the transaction will not be realized; the risk that the milestone associated with the CVR may not be achieved and that holders of CVRs may not receive payments in respect thereof; the impact of competitive products and pricing; other business effects, including the effects of industry, economic or political conditions outside of the companies’ control; transaction costs; actual or contingent liabilities; and other risks and uncertainties detailed from time to time in the companies’ periodic reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, as well as the Schedule 14D-9 filed by Arcellx and the Schedule TO and related tender offer documents filed by Gilead and Ravens Sub, Inc., a wholly owned subsidiary of Gilead. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation and disclaims any intent to update any such forward-looking statements.

Gilead, Kite, Arcellx and the Gilead logo are trademarks of Gilead Sciences, Inc., or its related companies.

For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).

More News From Gilead Sciences, Inc.
2026-06-12 17:01 2mo ago
2026-04-27 14:33 4mo ago
Rollins: Despite Margin Declines, I Remain Confident In This Niche Market Leader
ROL Rollins
FMP Stock News
Original source text
Rollins, Inc. in Q1 2026 saw 10% revenue growth (6.6% organic), with management reaffirming 7–8% organic and 2–3% M&A growth targets. Recent acquisitions, notably Romex for $90M, expand ROL's southern U.S. footprint and reinforce its M&A-driven growth strategy. Rollins remains a high-quality business yet trades at a premium P/E. I plan to add more shares if the stock falls to or below $50.
2026-06-12 17:01 2mo ago
2026-04-28 10:50 4mo ago
Rollins (ROL) is a Top-Ranked Momentum Stock: Should You Buy?
ROL Rollins
FMP Stock News
Original source text
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

#1 (Strong Buy) stocks have produced an unmatched +23.93% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Rollins (ROL - Free Report) Headquartered in Atlanta, GA, Rollins provides pest and termite control services to residential and commercial customers. The company offers protection against termite damage, insects, and rodents to homes and businesses, including food manufacturers, food service establishments, hotels, transportation companies, and retailers.

ROL is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.

Momentum investors should take note of this Business Services stock. ROL has a Momentum Style Score of A, and shares are up 5.5% over the past four weeks.

Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.00 to $1.24 per share. ROL boasts an average earnings surprise of +1.4%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, ROL should be on investors' short list.
2026-06-12 17:01 2mo ago
2026-04-28 13:27 4mo ago
Waste Connections Stock Gains 3.2% Since Q1 Earnings Beat
ROL Rollins
FMP Stock News
Original source text
Key Takeaways WCN's Q1 earnings beat estimates by 3.4% and rose 8.9% year over year, lifting shares by 3.2%.Waste Connections saw revenue growth in core waste segments, driven by strong pricing gains.Waste Connections' recycling revenues fell 12.9% y/y, while the E&P waste segment jumped 24.2% y/y. Waste Connections, Inc. (WCN - Free Report) reported impressive first-quarter 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.

WCN’s first-quarter earnings of $1.23 per share beat the Zacks Consensus Estimate by 3.4% and increased 8.9% year over year. Total revenues came in at $2.4 billion, marginally surpassing the consensus estimate and rising 6.4% from the year-ago quarter.

The better-than-expected results impressed investors, as the stock has gained 3.2% since the company released results on April 22.

Over the past year, WCN shares have plummeted 17.4% compared with the industry's 7.9% decline. The Zacks S&P 500 composite has gained 32.9% during the said time frame.

WCN’s Q1 Segmental InformationThe company logged $1.7 billion in revenues from the Solid Waste Collection segment, which gained 5.4% year over year. In the Solid Waste Disposal and Transfer segment, revenues increased 6.7% from the year-ago quarter to $386.1 million. These segments improved, backed by solid core pricing.

The Solid Waste Recycling segment witnessed a 12.9% year-over-year decline in revenues to $51.6 million. For the E&P Waste Treatment, Recovery and Disposal segment, revenues totaled $179.5 million, marking a 24.2% year-over-year increase. The Intermodal and Other segment recorded $49 million in revenues, up 6.1% from the year-ago quarter.

WCN’s Operating ResultsAdjusted EBITDA in the reported quarter was $769.5 million, up 8% from the year-ago quarter. The adjusted EBITDA margin was 32.5%, up 50 basis points from the first quarter of 2025.

The company recorded an operating income of $390.2 million, which rose 7.1% from the year-ago quarter’s recorded figure.

Key Balance Sheet & Cash Flow MetricsWaste Connections exited the first quarter of 2026 with cash and cash equivalents of $112.4 million, up from $46 million in the preceding quarter. The long-term portion of debt and notes payable was $9 billion, compared with $8.8 billion in the fourth quarter of 2025.

In the reported quarter, WCN generated $546 million in cash from operating activities. The adjusted free cash flow was $245.9 million. Capital expenditure totaled $296.6 million. The company paid out $88.7 million in dividends during the quarter.

Waste Connections carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Earnings SnapshotsEquifax Inc. (EFX - Free Report) reported better-than-expected first-quarter 2026 results. EFX’s adjusted earnings per share of $1.86 beat the Zacks Consensus Estimate by 10.1% and increased 21.6% from the year-ago quarter. EFX’s revenues of $1.6 billion surpassed the consensus estimate by 2.3% and improved 14.4% year over year.

Rollins, Inc. (ROL - Free Report) posted impressive first-quarter 2026 results. ROL’s adjusted earnings of 24 cents per share matched the consensus mark and rose 9.1% from the year-ago quarter. ROL’s total revenues of $906.4 million surpassed the consensus mark by 1.3% and increased 10.2% year over year.
2026-06-12 17:01 2mo ago
2026-04-29 14:10 4mo ago
Rollins, Inc. $ROL Shares Purchased by Concurrent Investment Advisors LLC
ROL Rollins
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 29th, 2026

Concurrent Investment Advisors LLC lifted its holdings in Rollins, Inc. (NYSE:ROL – Free Report) by 65.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,265 shares of the business services provider’s stock after purchasing an additional 17,546 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Rollins were worth $2,657,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Board of the Pension Protection Fund acquired a new stake in shares of Rollins in the 4th quarter worth $30,000. Root Financial Partners LLC acquired a new stake in shares of Rollins in the 3rd quarter worth $31,000. TruNorth Capital Management LLC acquired a new stake in shares of Rollins in the 3rd quarter worth $45,000. First Horizon Corp acquired a new stake in shares of Rollins in the 3rd quarter worth $47,000. Finally, MUFG Securities EMEA plc acquired a new stake in shares of Rollins in the 2nd quarter worth $47,000. Institutional investors and hedge funds own 51.79% of the company’s stock.

Rollins Stock Performance NYSE ROL opened at $55.71 on Wednesday. The stock has a 50-day simple moving average of $56.01 and a two-hundred day simple moving average of $58.64. The firm has a market capitalization of $26.82 billion, a P/E ratio of 51.11, a PEG ratio of 3.45 and a beta of 0.84. Rollins, Inc. has a fifty-two week low of $52.32 and a fifty-two week high of $66.14. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 0.65.

Rollins (NYSE:ROL – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The business services provider reported $0.24 earnings per share for the quarter, meeting the consensus estimate of $0.24. Rollins had a return on equity of 38.37% and a net margin of 13.77%.The firm had revenue of $906.42 million during the quarter, compared to analyst estimates of $895.17 million. During the same quarter in the previous year, the business earned $0.22 EPS. Rollins’s revenue for the quarter was up 10.2% compared to the same quarter last year. On average, equities analysts forecast that Rollins, Inc. will post 1.24 earnings per share for the current year.

Rollins Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 10th. Investors of record on Monday, May 11th will be paid a $0.1825 dividend. This represents a $0.73 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Monday, May 11th. Rollins’s payout ratio is currently 66.97%.

Insider Buying and Selling at Rollins In related news, insider Elizabeth B. Chandler sold 14,201 shares of Rollins stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $59.36, for a total value of $842,971.36. Following the completion of the transaction, the insider owned 55,977 shares in the company, valued at $3,322,794.72. The trade was a 20.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 5.77% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades ROL has been the subject of a number of research reports. Canaccord Genuity Group set a $51.00 price target on Rollins and gave the stock a “hold” rating in a research report on Friday. Wells Fargo & Company set a $56.00 price target on Rollins and gave the stock an “equal weight” rating in a research report on Thursday, February 12th. Royal Bank Of Canada set a $67.00 price target on Rollins and gave the stock an “outperform” rating in a research report on Thursday, February 12th. Bank of America initiated coverage on Rollins in a research report on Tuesday, February 17th. They set a “buy” rating and a $67.00 price target for the company. Finally, Morgan Stanley set a $70.00 price target on Rollins in a research report on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Rollins presently has a consensus rating of “Moderate Buy” and an average target price of $65.27.

Check Out Our Latest Stock Report on ROL

Rollins Profile (Free Report)

Rollins, Inc (NYSE: ROL) is a provider of pest and termite control services operating through a network of subsidiaries and franchises. Headquartered in Atlanta, Georgia, the company offers a broad range of pest management solutions for both residential and commercial customers, positioning itself as a specialist in protecting property and public health from pests and vectors.

Its service offerings include general pest control, termite inspection and treatment, bed bug remediation, mosquito and vector control, wildlife exclusion, and related specialty services.

Recommended Stories Five stocks we like better than Rollins Want to see what other hedge funds are holding ROL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rollins, Inc. (NYSE:ROL – Free Report).

Receive News & Ratings for Rollins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rollins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEConcurrent Investment Advisors LLC Raises Stock Position in Ares Management Corporation $ARES

NEXT HEADLINE »Concurrent Investment Advisors LLC Buys 10,467 Shares of PulteGroup, Inc. $PHM
2026-06-12 17:01 2mo ago
2026-05-01 10:40 4mo ago
Innovations & Strategic Buyouts Aid Rollins Amid Integration Risk
ROL Rollins
FMP Stock News
Original source text
ROL's growth rides on tech-driven efficiency and steady acquisitions. Its rising costs, integration risks and liquidity concerns could weigh on margins.
2026-06-12 17:01 2mo ago
2026-05-04 11:32 4mo ago
Polen Focus Growth Portfolio Q1 2026 Portfolio Update
ROL Rollins
FMP Stock News
Original source text
In Q1 2026, Polen Focus Growth Portfolio returned -17.27% (net of fees) compared to -9.78% for the Index. Starbucks was the top performing absolute and relative contributor in Q1 amid positive signs that CEO Brian Nicol's multi-year turnaround strategy is beginning to bear fruit. In Q1 2026, we initiated new positions in Lam Research, Meta and Rollins, while we sold our holdings in Abbott Laboratories, Adobe, and Boston Scientific, Paycom and Intuit.
2026-06-12 17:01 2mo ago
2026-05-05 07:53 4mo ago
Los Angeles Holds Top Spot as Worst City for Mosquitoes as Activity Climbs Nationwide
ROL Rollins
FMP Stock News
Original source text
A decade ago, Atlanta led the nation in mosquito activity—in its 6th year running, Los Angeles has firmly taken that title

, /PRNewswire/ -- As mosquito season kicks off across the U.S., Orkin's 2026 Mosquito Cities List reveals a significant shift in mosquito activity across the U.S. and where these unwelcome pests are making the biggest buzz. While Los Angeles, Chicago and New York hold the top three spots, the broader top 50 list shows mosquito activity expanding beyond traditional hotspots and reaching more regions across the country.

Data over time shows a clear geographic change. For six consecutive years, from 2015 through 2020, Atlanta held the top spot. Since 2021, Los Angeles has consistently ranked No. 1, marking a shift in the highest levels of mosquito activity. A pest issue that was once concentrated in the Southeast has evolved into a nationwide concern, with cities across every region now facing risks from this pest.

Beyond being a nuisance, mosquitoes are the deadliest animal in the world, responsible for more than 600,000 malaria-related deaths each year, according to the Centers for Disease Control and Prevention. In the U.S., they can spread serious diseases including West Nile virus, Eastern Equine Encephalitis and Zika. Additionally, mosquito-borne diseases that were once rare or uncommon in the U.S., such as dengue fever, are rising significantly, making prevention especially important as activity increases during peak season.

As part of its ongoing commitment to public health, Orkin continues its partnership with the American Red Cross through its Mosquitoes Don't Deserve a Drop campaign, helping raise awareness of mosquito-borne risks while supporting the nation's blood supply during peak season. From May to August 2026, for every mosquito control service purchased, Orkin will donate $25 to the American Red Cross, up to $250,000.

The rankings are based on the number of new residential mosquito treatments performed by Orkin from March 18, 2025, to March 18, 2026.

1. Los Angeles

26. Oklahoma City (-2) 

2. Chicago

27. Pittsburgh (+1) 

3. New York 

28. Grand Rapids, Mich. (-3)

4. Detroit (+1)

29. Norfolk, Va. (-2)

5. Atlanta (-1)

30. Cincinnati (-1)

6. Washington, D.C. (+2)

31. Richmond, Va. (-1)

7. Houston (-1)

32. St. Louis (+15)

8. Dallas (-1)

33. Flint, Mich. (-2)

9. Cleveland

34. Boston (+6)

10. Denver

35. Knoxville, Tenn. (+1)

11. Raleigh, N.C. (+2)

36. West Palm Beach, Fla. (+6)

12. Charlotte, N.C. (+2)

37. Tulsa, Okla. (-5)

13. Minneapolis (+6)

38. Albuquerque, N.M. (-3)

14. Philadelphia (-3)

39. Sacramento, Calif. (new)

15. Indianapolis (+1)

40. Phoenix (new)

16. Tampa, Fla. (+2)

41. San Antonio (-4)

17. Miami (-5)

42. Cedar Rapids, Iowa (-9)

18. San Francisco (-3) 

43. Traverse City, Mich. (new)

19. Orlando, Fla. (-2)

44. Hartford, Conn. (+1)

20. Columbus, Ohio (+3)

45. San Diego (-6)

21. Greenville, S.C. (+1)

46. Columbia, S.C. (-5)

22. Baltimore (-2)

47. Springfield, Ill. (new)

23. Milwaukee (+15) 

48. Memphis, Tenn. (-14)

24. Seattle (+2)

49. Greenville, N.C. (new)

25. Nashville, Tenn. (-4) 

50. Greensboro, N.C. (-5)

"Over the past decade, we've seen mosquito activity expand beyond traditional hotspots and become a nationwide concern," said Shannon Sked, Orkin entomologist. "While major cities continue to experience consistent pressure, emerging trends—especially in the Midwest—show how shifting climate conditions and the expanding range of the yellow fever mosquito are creating new hotspots across the country."

Midwestern cities continue to see some of the fastest growth year-over-year, with Milwaukee jumping 15 spots to No. 23 and Minneapolis climbing six spots to No. 13. At the same time, some historically high-ranking cities saw declines, with Miami and Greensboro, N.C. each dropping five spots. Changes like these underscore how environmental factors, including the spread of species like the yellow fever mosquito (Aedes aegypti), are reshaping mosquito pressures across the country.

Several new cities appeared on this year's list, including first-time entries Traverse City, Mich., Greenville, N.C. and Springfield, Ill., alongside returning cities like Sacramento, Calif. and Phoenix. Together, they highlight how mosquito activity is expanding into regions not traditionally associated with high levels of mosquito pressure. 

To help reduce mosquito activity, Orkin recommends using the acronym BITE to remember key prevention steps:

Block access to skin by wearing long sleeves and pants, as well as CDC-recommended repellents. Install tight-fitting screens on windows and doors. Trim shrubs, grass and other vegetation to reduce mosquito resting areas. Eliminate standing water, which is a breeding ground for mosquitoes. For more mosquito facts and prevention tips, visit Orkin.com.

About Orkin, LLC  
Founded in 1901, Atlanta-based Orkin has been shaping the pest control industry for 125 years, providing protection against termite damage, rodents and insects through its commitment to scientific knowledge and unmatched training. From its earliest days to today, Orkin's innovative spirit continues to define the future of pest management. 

Orkin is dedicated to protecting the places where we live, work and play by helping prevent and control pests and educating consumers about the potential health risks they pose. Guided by a service-first mission to deliver peace of mind, Orkin Pros are trusted professionals who embody the company's values of safety, integrity, professionalism, empathy and innovation. Since 2020, Orkin has partnered with the American Red Cross® to raise awareness about mosquito-borne health threats while supporting the nation's blood supply through monetary contributions and blood donations.

Orkin has more than 400 owned and operated branch offices and nearly 50 franchises in the U.S. The company also has international franchises and subsidiaries in Canada, Europe, Central America, South America, the Caribbean, the Middle East, Asia, the Mediterranean, Africa and Mexico. Learn more about careers at Orkin here.

Visit Orkin.com for additional information. Orkin is a wholly-owned subsidiary of Rollins Inc. (NYSE: ROL). Follow us on Facebook, Instagram, TikTok and LinkedIn.  

SOURCE Orkin, LLC
2026-06-12 17:01 2mo ago
2026-05-07 14:51 4mo ago
Rollins: Demand Held Up, But Ebitda Impacted By Non-Structural Reasons
ROL Rollins
FMP Stock News
Original source text
Rollins remains a buy as growth momentum and demand resilience persist, despite a noisy Q1 2026 margin miss. Q1 2026 revenue grew ~10% y/y to $906.4M, with organic growth across all segments and a swift March rebound after weather disruptions. Adj. EBITDA margin fell 109 bps to 19.8%, but margin weakness is attributed to non-structural, transient cost factors likely to normalize.